From 9877394cdcbd5f0308e6f754c3fcb40422d2ca34 Mon Sep 17 00:00:00 2001 From: Slimmer bot Date: Tue, 8 Oct 2024 14:09:41 +0000 Subject: [PATCH] Actions - slim updated --- external-dev/aopo-slim.owl | 8 +- external-dev/bao-slim-prop.owl | 6 +- external-dev/bao-slim.owl | 2 +- external-dev/bfo-slim.owl | 2 +- external-dev/bto-slim.owl | 2 +- external-dev/ccont-slim.owl | 2 +- external-dev/chebi-slim.owl | 6 +- external-dev/cheminf-slim-prop.owl | 6 +- external-dev/cheminf-slim.owl | 2 +- external-dev/chmo-slim.owl | 2 +- external-dev/clo-slim.owl | 48 +- external-dev/efo-slim.owl | 2637 +++++++++------------------- external-dev/envo-slim.owl | 178 +- external-dev/fabio-slim.owl | 2 +- external-dev/go-slim.owl | 71 +- external-dev/iao-slim.owl | 2 +- external-dev/msio-slim.owl | 2 +- external-dev/ncit-slim.owl | 2 +- external-dev/npo-slim-prop.owl | 6 +- external-dev/npo-slim.owl | 2 +- external-dev/oae-slim.owl | 2 +- external-dev/obcs-slim.owl | 2 +- external-dev/obi-slim.owl | 2 +- external-dev/pato-slim.owl | 908 +--------- external-dev/sio-slim-prop.owl | 6 +- external-dev/sio-slim.owl | 2 +- external-dev/uberon-slim.owl | 91 +- external-dev/uo-slim.owl | 2 +- 28 files changed, 1243 insertions(+), 2760 deletions(-) diff --git a/external-dev/aopo-slim.owl b/external-dev/aopo-slim.owl index 409cefec..dc249b43 100644 --- a/external-dev/aopo-slim.owl +++ b/external-dev/aopo-slim.owl @@ -44,15 +44,15 @@ https://raw.githubusercontent.com/jmillanacosta/aop-ontology/patch-1/aopo.owl Slimmer - 2024-07-01 01:44:32 - 27:05:2024 20:32 + 2024-10-08 14:02:40 + 27:07:2024 19:59 chebi_ontology human_phenotype 1.2 has_part chebi Author: ChEBI curation team - ChEBI Release version 234 + ChEBI Release version 236 ChEBI subsumes and replaces the Chemical Ontology first Contact: Stephan Schurer @@ -102,7 +102,7 @@ Uma Vempati, Hande Küçük, Ubbo Visser, Saminda Abeyruwan, Kunie Sakurai, Vanc 2.8.6 2.8.8 2.8.9 - 2024-06-27 + 2024-08-13 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/bao-slim-prop.owl b/external-dev/bao-slim-prop.owl index 9b0f8784..ae545f8d 100644 --- a/external-dev/bao-slim-prop.owl +++ b/external-dev/bao-slim-prop.owl @@ -1,6 +1,6 @@ - - + diff --git a/external-dev/bao-slim.owl b/external-dev/bao-slim.owl index 36144c58..8e652fab 100644 --- a/external-dev/bao-slim.owl +++ b/external-dev/bao-slim.owl @@ -24,7 +24,7 @@ http://bioassayontology.org/bao/bao_complete_merged.owl Slimmer - 2024-07-01 01:44:39 + 2024-10-08 14:02:48 Contact: Stephan Schurer stephan dot schurer at gmail dot com diff --git a/external-dev/bfo-slim.owl b/external-dev/bfo-slim.owl index da21ac28..2cc638e7 100644 --- a/external-dev/bfo-slim.owl +++ b/external-dev/bfo-slim.owl @@ -45,7 +45,7 @@ http://purl.obolibrary.org/obo/bfo/classes-only.owl Slimmer - 2024-07-01 01:44:41 + 2024-10-08 14:02:50 The http://purl.obolibary.org/obo/bfo/classes-only.owl variant of BFO ("bfo_classes_only.owl") includes only the class hierarchy and annotations from the full OWL version of BFO 2: http://purl.obolibary.org/obo/bfo.owl ("bfo.owl"). There are no object properties or logical axioms that use the object properties in bfo_classes_only.owl. As the logical axioms in the bfo_classes_only.owl variant are limited to subclass and disjoint assertions they are much weaker than the logical axioms in bfo.owl. If you plan to use the relations that define BFO 2, you should import bfo.owl instead of bfo_classes_only.owl. To the extent that the relations are used without importing bfo.owl, be mindful that they should be used in a manner consistent with their use in bfo.owl. Otherwise if your ontology is imported by a another ontology that imports bfo.owl there may be inconsistencies. diff --git a/external-dev/bto-slim.owl b/external-dev/bto-slim.owl index 9f41fa45..b46fd99d 100644 --- a/external-dev/bto-slim.owl +++ b/external-dev/bto-slim.owl @@ -20,7 +20,7 @@ http://purl.obolibrary.org/obo/bto.owl OBO-Edit 2.3.1 Slimmer - 2024-07-01 01:44:46 + 2024-10-08 14:02:55 23:10:2021 16:56 BrendaTissueOBO 1.2 diff --git a/external-dev/ccont-slim.owl b/external-dev/ccont-slim.owl index 2ff27d47..c95ef88e 100644 --- a/external-dev/ccont-slim.owl +++ b/external-dev/ccont-slim.owl @@ -15,7 +15,7 @@ https://raw.githubusercontent.com/enanomapper/ontologies/master/internal/ccont-ext.owl Matthias Ganzinger, matthias.ganzinger@med.uni-heidelberg.de Slimmer - 2024-07-01 01:44:47 + 2024-10-08 14:02:56 cell culture ontology (CCONT) 1.1 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/chebi-slim.owl b/external-dev/chebi-slim.owl index ec347172..0dae10b9 100644 --- a/external-dev/chebi-slim.owl +++ b/external-dev/chebi-slim.owl @@ -17,13 +17,13 @@ http://ftp.ebi.ac.uk/pub/databases/chebi/ontology/chebi_lite.obo Slimmer - 2024-07-01 01:46:26 - 27:05:2024 20:32 + 2024-10-08 14:03:37 + 27:07:2024 19:59 chebi_ontology 1.2 chebi Author: ChEBI curation team - ChEBI Release version 234 + ChEBI Release version 236 ChEBI subsumes and replaces the Chemical Ontology first For any queries contact chebi-help@ebi.ac.uk developed by Michael Ashburner & Pankaj Jaiswal. diff --git a/external-dev/cheminf-slim-prop.owl b/external-dev/cheminf-slim-prop.owl index 780c204b..c1d4c89e 100644 --- a/external-dev/cheminf-slim-prop.owl +++ b/external-dev/cheminf-slim-prop.owl @@ -1,12 +1,12 @@ - - + diff --git a/external-dev/cheminf-slim.owl b/external-dev/cheminf-slim.owl index 15541c63..48fc516b 100644 --- a/external-dev/cheminf-slim.owl +++ b/external-dev/cheminf-slim.owl @@ -80,7 +80,7 @@ http://creativecommons.org/publicdomain/zero/1.0/ http://semanticchemistry.github.io/semanticchemistry/ontology/cheminf.owl Slimmer - 2024-07-01 01:44:50 + 2024-10-08 14:02:59 An information artifact is, loosely, a dependent continuant or its bearer that is created as the result of one or more intentional processes. Examples: uniprot, the english language, the contents of this document or a printout of it, the temperature measurements from a weather balloon. For more information, see the project home page at https://github.com/information-artifact-ontology/IAO Document containing upporting external terms IDs allocated to related efforts: PNO: IAO_0020000-IAO_0020999, D_ACTS: IAO_0021000-IAO_0021999 diff --git a/external-dev/chmo-slim.owl b/external-dev/chmo-slim.owl index db18e305..14bb8fd6 100644 --- a/external-dev/chmo-slim.owl +++ b/external-dev/chmo-slim.owl @@ -19,7 +19,7 @@ http://purl.obolibrary.org/obo/chmo.owl Slimmer - 2024-07-01 01:46:31 + 2024-10-08 14:03:43 1.2 batchelorc This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/clo-slim.owl b/external-dev/clo-slim.owl index 8843be7f..4f441e12 100644 --- a/external-dev/clo-slim.owl +++ b/external-dev/clo-slim.owl @@ -39,9 +39,9 @@ http://purl.obolibrary.org/obo/cl.owl Slimmer - 2024-07-01 01:46:43 - See PMID:15693950, PMID:12799354, PMID:20123131, PMID:21208450; Contact Alexander Diehl, addiehl@buffalo.edu, University at Buffalo. - 2024-05-15 + 2024-10-08 14:03:55 + See PMID:15693950, PMID:12799354, PMID:20123131, PMID:21208450; Contact Alexander Diehl, addiehl@buffalo.edu, university at buffalo. + 2024-09-26 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. @@ -431,6 +431,15 @@ WHERE { + + + + + + + + + @@ -1159,6 +1168,13 @@ WHERE { + + + + + + + @@ -1166,6 +1182,13 @@ WHERE { + + + + + + + @@ -1210,18 +1233,14 @@ WHERE { - - created by - + - - creation date - + @@ -1323,9 +1342,7 @@ WHERE { - - id - + @@ -1599,7 +1616,7 @@ WHERE { A cell that is maintained or propagated in a controlled artificial environment for use in an investigation. - 2012-01-12T09:58:38Z + 2012-01-12T09:58:38Z 'In vitro', translating literally to 'in glass', typically refers to a controlled, often sterile, laboratory setting where cells or other specimens are placed by some agent for the purpose of studying or manipulating them as part of some research investigation. 'In vitro' is intended to contrast with 'native',which refers to cells or other biological entities that are found in a natural setting. It describes unicellular organisms removed from a natural environement and multicellular organism cells removed from an organism, or cells derived in culture from such displaced cells. cell in vitro @@ -1616,12 +1633,11 @@ WHERE { - A connective tissue cell found in bone. - 2011-11-16T04:28:16Z + 2011-11-16T04:28:16Z bone cell @@ -1643,7 +1659,7 @@ WHERE { Skeletogenic cell that has the potential to transform into an osteoblast, and develops from neural crest or mesodermal cells. - 2012-06-27T10:57:21Z + 2012-06-27T10:57:21Z osteoprogenitor cell preosteoblast diff --git a/external-dev/efo-slim.owl b/external-dev/efo-slim.owl index bbdcd51a..c6a04ecd 100644 --- a/external-dev/efo-slim.owl +++ b/external-dev/efo-slim.owl @@ -27,8 +27,7 @@ xmlns:chebi6="http://purl.obolibrary.org/obo/chebi#2" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:patterns="http://www.co-ode.org/patterns#" - xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#" - xmlns:mondo-base="http://purl.obolibrary.org/obo/mondo/mondo-base#"> + xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#"> 1.4 Catherine Leroy @@ -56,9 +55,9 @@ License. www.apache.org/licenses/LICENSE-2.0 http://www.ebi.ac.uk/efo/efo.owl Slimmer - 2024-07-01 01:47:52 - 2024-06-17 - 3.67.0 + 2024-10-08 14:05:16 + 2024-09-16 + 3.70.0 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. @@ -97,6 +96,20 @@ License. + + + + + + + + + + + + + + @@ -186,6 +199,13 @@ License. + + + + + + + @@ -195,6 +215,13 @@ License. + + + + + + + @@ -204,6 +231,13 @@ License. + + + + + + + @@ -218,6 +252,20 @@ License. + + + + + + + + + + + + + + @@ -225,6 +273,13 @@ License. + + + + + + + @@ -325,6 +380,23 @@ Add as annotation triples in the granting ontology + + + + + If R <- P o Q is a defining property chain axiom, then (1) R -> P o Q holds and (2) Q is either reflexive or locally reflexive. A corollary of this is that P SubPropertyOf R. + is a defining property chain axiom where second argument is reflexive + + + + + + + + + + + @@ -711,59 +783,24 @@ This annotation property may be replaced with an annotation property from an ext - - - - - - - - - - - - - - - - - - - - - - + - + - + - + - - - - - - - - - - - - - - - + - + @@ -1378,6 +1415,13 @@ This annotation property may be replaced with an annotation property from an ext + + + + + + + @@ -1413,6 +1457,13 @@ This annotation property may be replaced with an annotation property from an ext + + + + + + + @@ -1460,1130 +1511,10 @@ This annotation property may be replaced with an annotation property from an ext - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + @@ -2635,58 +1566,54 @@ This annotation property may be replaced with an annotation property from an ext + quality + Quality + the ambient temperature of this portion of air + the color of a tomato + the length of the circumference of your waist + the mass of this piece of gold. + the shape of your nose + the shape of your nostril A quality is an entity that describes some aspect which is intrinsic to that particular object and is dependent on or more material entities in which it inheres in or is borne by. Example the color of a tomato, the ambient temperature of air, the circumference of a waist, the shape of a nose, the mass of a piece of gold, the weight of a chimpanzee James Malone + a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001]) + If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001]) + (forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001] + (forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001] http://www.ebi.ac.uk/efo/EFO_0001436 true A specifically dependent continuant [snap:SpecificallyDependentContinuant] that is exhibited if it inheres in an entity or entities at all (a categorical property). http://www.ifomis.org/bfo/1.1/snap#Quality NCIt:C25283 SNOMEDCT:263496004 + + quality quality - - - - - - - - - - -Established from a human primary embryonal kidney transformed by adenovirus type 5. - - - BrendaTissueOBO - 293 cell - A-293 cell - A293 cell - HEK cell - HEK293 cell - human embryonal kidney cell - human embryonic kidney cell - BTO:0000007 - HEK-293 cell - - - - - - - - - - -Human lung carcinoma established from an explanted lung tumor which was removed from a 58-year-old Caucasian man in 1972; cells were described to induce tumors in athymic mice and to synthesize lecithin. - - - BrendaTissueOBO - A549 cell - NCI-A549 cell - BTO:0000018 - A-549 cell - + + + + (forall (x) (if (Quality x) (SpecificallyDependentContinuant x))) // axiom label in BFO2 CLIF: [055-001] + + + + + + (forall (x) (if (exists (t) (and (existsAt x t) (Quality x))) (forall (t_1) (if (existsAt x t_1) (Quality x))))) // axiom label in BFO2 CLIF: [105-001] + + + + + + a quality is a specifically dependent continuant that, in contrast to roles and dispositions, does not require any further process in order to be realized. (axiom label in BFO2 Reference: [055-001]) + + + + + + If an entity is a quality at any time that it exists, then it is a quality at every time that it exists. (axiom label in BFO2 Reference: [105-001]) + + @@ -2788,7 +1715,7 @@ A cell line of leukemia characterized by proliferation of myeloid tissue (as of - + BrendaTissueOBO colon cancer cell line @@ -2862,34 +1789,6 @@ Mouse, BALB/cxNZB F1, lymphoblastic lymphoma cell line. Morphology: Lymphoblast - - - - - - -Rat, nervous system, immature, Schwann cell derived cell line. - - - BrendaTissueOBO - D6P2T cell - BTO:0001205 - RT4-D6P2T cell - - - - - - - - - - Mouse pro B cell line. IL-3 dependent murine pro B cell line established from peripheral blood; apparently derived from BALB/c mouse. - BA/F3 cell - - - - @@ -2981,18 +1880,6 @@ Rat, nervous system, immature, Schwann cell derived cell line. - - - - - - "The 184A1N4 and 184B5 cell lines are nontumorigenic cell lines derived from primary cultures of HMECs that were immortalized with benzo(a)pyrene." [PMID:15827326] - BrendaTissueOBO - 184B5 cell - - - - @@ -3061,23 +1948,6 @@ Rat, nervous system, immature, Schwann cell derived cell line. - - - - - - -A cardiac muscle cell line from the AT-1 mouse atrial cardiomyocyte tumor lineage; established from an adult female Jackson Laboratory-inbred C57BLy6J mouse. - - - BrendaTissueOBO - HL1 cell - BTO:0003264 - HL-1 cell - - - - @@ -3126,24 +1996,6 @@ A cardiac muscle cell line from the AT-1 mouse atrial cardiomyocyte tumor lineag - - - - - - Mouse embryonic stem cell line. - - XPMUser - 2011-05-11T10:03:05Z - BrendaTissueOBO - E-14 cell - E14 cell - BTO:0005136 - ES-E14 cell - - - - @@ -8776,6 +7628,12 @@ Established melanoma cell line from the Skin Cancer Unit at the German Cancer Re HP:0001522 Death in infancy + + + + Death within the first 24 months of life. + + @@ -8800,12 +7658,6 @@ Established melanoma cell line from the Skin Cancer Unit at the German Cancer Re Death in early childhood - - - - Death within the first 24 months of life. - - @@ -9019,7 +7871,6 @@ Established melanoma cell line from the Skin Cancer Unit at the German Cancer Re HP:0003664 HP:0003668 HP:0011007 - MSH:D017668 MeSH:D017668 UMLS:C0206132 Age of onset @@ -9052,7 +7903,6 @@ Established melanoma cell line from the Skin Cancer Unit at the German Cancer Re Death within the first 28 days of life. HP:0003820 HP:0003824 - MSH:D066087 SNOMEDCT_US:276506001 UMLS:C0410916 Neonatal lethal @@ -9082,8 +7932,6 @@ Established melanoma cell line from the Skin Cancer Unit at the German Cancer Re Death of the fetus in utero after at least 22 weeks of gestation. HP:0001624 HP:0001625 - MSH:D005313 - MSH:D050497 SNOMEDCT_US:237364002 SNOMEDCT_US:276507005 UMLS:C0015927 @@ -9151,7 +7999,6 @@ Established melanoma cell line from the Skin Cancer Unit at the German Cancer Re A pregnancy that ends at a stage in which the fetus is incapable of surviving on its own, defined as the spontaneous loss of a fetus before the 22th week of pregnancy. - MSH:D000022 SNOMEDCT_US:17369002 UMLS:C0000786 Early fetal demise @@ -10380,9 +9227,14 @@ A 267b1 ki ras derives from a prostate. + James Malone + BTO:0002181 + CLO:0037372 + RRID:CVCL_0063 293T + HEK293T @@ -11256,9 +10108,11 @@ A 267b1 ki ras derives from a prostate. + + Ele Holloway James Malone - H720 + NCI-H720 @@ -11532,21 +10386,6 @@ A 267b1 ki ras derives from a prostate. - - - - - - - James Malone - BTO:0002181 - CLO:0037372 - RRID:CVCL_0063 - HEK293T - - - - @@ -11612,20 +10451,6 @@ A 267b1 ki ras derives from a prostate. - - - - - - - - - James Malone - HMEC S1 - - - - @@ -11645,9 +10470,12 @@ A 267b1 ki ras derives from a prostate. + James Malone + PMID:16849555 + HMEC S1 HMT3522S1 @@ -12011,7 +10839,6 @@ A 267b1 ki ras derives from a prostate. - James Malone MM1 @@ -12044,7 +10871,6 @@ A 267b1 ki ras derives from a prostate. - A cell line derived from bone marrow multiple myeloma B cells. @@ -12083,19 +10909,6 @@ A 267b1 ki ras derives from a prostate. - - - - - - - - James Malone - NIH3T3-L1 - - - - @@ -12292,8 +11105,11 @@ A 267b1 ki ras derives from a prostate. - + + + Human SUM1315- metastatic/invasive breast ductal carcinoma cell line James Malone + Kalpana Panneerselvam CLO:0009916 RRID:CVCL_5589 SUM1315MO2 @@ -12477,10 +11293,14 @@ A 267b1 ki ras derives from a prostate. - + + Epithelial cells derived from human breast tumour James Malone - T47D + Kalpana Panneerselvam + CLO:0009251 + RRID:CVCL_0553 + T-47D cell @@ -12536,7 +11356,6 @@ A TERV derives from a kidney. - A human cell line derived from peripheral blood monocytes. The patient was a 1-year-old male infant with acute monocytic leukemia. @@ -12555,7 +11374,6 @@ A TERV derives from a kidney. - James Malone BTO:0001594 @@ -13002,7 +11820,7 @@ A g1e er4 is a GATA-1-null erythroblast. - + Ele Holloway James Malone BTO:0002722 @@ -13186,9 +12004,14 @@ A g1e er4 is a GATA-1-null erythroblast. + Human with IEF of AST, LDH, NP established from the biopsy from a fibrosarcoma of a 35-year-old Caucasian man in 1972 Ele Holloway James Malone + Kalpana Panneerselvam https://www.atcc.org/Products/All/CCL-121.aspx + CLO:0004276 + RRID:CVCL_0317 + HT-1080 cell HT1080 @@ -13905,7 +12728,6 @@ A Kc derives from a drosophila melanogaster. - A cell line derived from human acute myeloid leukemia. @@ -14125,7 +12947,6 @@ A Kc derives from a drosophila melanogaster. - Ele Holloway @@ -15075,7 +13896,6 @@ A Daudi Burkitt's lymphoma cell line is bearer of Daudi Burkitt's lymp - Ele Holloway @@ -15215,8 +14035,11 @@ A Daudi Burkitt's lymphoma cell line is bearer of Daudi Burkitt's lymp + human hepatocellular carcinoma (HCC) cells (p53-null). Ele Holloway James Malone + Kalpana Panneerselvam + CLO:0003710 Hep-3B Hep3B @@ -15227,7 +14050,6 @@ A Daudi Burkitt's lymphoma cell line is bearer of Daudi Burkitt's lymp - @@ -15381,7 +14203,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - Ele Holloway @@ -15487,8 +14308,12 @@ A Jiyoye is bearer of a Burkitt's lymphoma. + Human Hodgkin lymphoma L-428 cells Ele Holloway James Malone + Kalpana Panneerselvam + CLO:0007189 + RRID:CVCL_1361 L428 @@ -15543,7 +14368,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - Ele Holloway @@ -15671,7 +14495,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - Ele Holloway @@ -15715,7 +14538,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - Ele Holloway @@ -15812,7 +14634,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - Ele Holloway @@ -16567,10 +15388,9 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - - Ele Holloway - James Malone - NCI-H720 + + http://www.ebi.ac.uk/efo/EFO_0001166 + obsolete_H720 @@ -16712,7 +15532,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - Ele Holloway @@ -16728,12 +15547,22 @@ A Jiyoye is bearer of a Burkitt's lymphoma. + RCH-ACV cell line is a human B cell precursor leukemia cell line established from a bone marrow sample of a child with acute lymphoblastic leukemia. Ele Holloway James Malone + paola + RCH BTO:0003376 RRID:CVCL_1851 + RCHACV RCHACV + + + + RCH-ACV cell line is a human B cell precursor leukemia cell line established from a bone marrow sample of a child with acute lymphoblastic leukemia. + PMID:3455845 + @@ -16849,7 +15678,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - @@ -16964,19 +15792,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - - - - - - - Ele Holloway - James Malone - SJRH30 - - - - @@ -17087,7 +15902,6 @@ A Jiyoye is bearer of a Burkitt's lymphoma. - Ele Holloway @@ -17283,9 +16097,14 @@ A Jiyoye is bearer of a Burkitt's lymphoma. + Human anaplastic large T cell lymphoma cell line established from the pleural effusion an 11-year-old boy with CD30+ (Ki-1) large T cell lymphoma in 1983 (also described as "SR"); described to express the NPM1-ALK (NPM-ALK) fusion gene (DSMZ catalog number ACC 369) Ele Holloway James Malone + http://www.dsmz.de/catalogues/details/culture/ACC-369.html + BTO:0003585 + CLO:0009126 NCIt:C117126 + RRID:CVCL_1711 SR @@ -18296,7 +17115,6 @@ RX PubMed=11238448; DOI=10.1083/jcb.152.5.911; - @@ -18388,7 +17206,6 @@ RX PubMed=11238448; DOI=10.1083/jcb.152.5.911; - https://www.dsmz.de/catalogues/details/culture/ACC-207.html @@ -18446,26 +17263,6 @@ RX PubMed=11238448; DOI=10.1083/jcb.152.5.911; - - - - - - TH-1 - - - - - - - - - - TH-2 - - - - @@ -19709,7 +18506,7 @@ A MIN6 derives from a mus musculus. - + lymphoma or leukaemia cell line @@ -19785,7 +18582,6 @@ A MIN6 derives from a mus musculus. - Tomasz Adamusiak @@ -26589,7 +25385,6 @@ Small-inducible cytokine A11. - chronic myelogenous leukemia cell line @@ -27155,22 +25950,6 @@ Small-inducible cytokine A11. - - - - - - - Dani Welter - PMID:10353731 - PMID:20679594 - PMID:25485619 - HCC-2279 - HCC227 - - - - @@ -27394,7 +26173,6 @@ Carry an amplified HER-2 oncogene and to be insensitive to HER-2-inhibiting drug - @@ -27783,7 +26561,6 @@ Carry an amplified HER-2 oncogene and to be insensitive to HER-2-inhibiting drug - SKMM2 SK-MM-2 @@ -28398,7 +27175,7 @@ Carry an amplified HER-2 oncogene and to be insensitive to HER-2-inhibiting drug - + KMS-11 cell line was derived from four patients with multiple myeloma. These cells represent a later stage of B-cell differentiation, and shows characteristics of plasma cells by secreting surface kappa chain immunoglobulins. http://www.ncbi.nlm.nih.gov/pubmed/2768132 PMID:2519219 @@ -28786,6 +27563,8 @@ present. Hum Cell. 2002 Sep;15(3):104-17." The line was established from cells from the bone marrow of a child with rhabdomyosarcoma. Derived from a metastatic site of the bone marrow. The cells show ultrastructural elements of primitive skeletal muscle differentiation. + Ele Holloway + James Malone https://www.encodeproject.org/documents/f714cd44-747e-4a56-9c0f-ae7ea5715783/@@download/attachment/SJCRH30_SOP_V1.pdf BTO:0005379 CLO:0037074 @@ -28794,7 +27573,7 @@ present. Hum Cell. 2002 Sep;15(3):104-17." RH30 RMS 13 RMS13 - SJCRH30 + SJRH30 @@ -28818,7 +27597,6 @@ present. Hum Cell. 2002 Sep;15(3):104-17." - @@ -28892,7 +27670,7 @@ present. Hum Cell. 2002 Sep;15(3):104-17." - + An endothelial cell derived cell line is defined as a cell line that derives from an endothelial cell. Catherine Leroy Sirarat Sarntivijai @@ -30254,7 +29032,6 @@ http://humupd.oxfordjournals.org/content/13/2/103.full - A monocytic cell line, termed Mono Mac, was established from peripheral blood of a patient with monoblastic leukemia. Two clones, designated Mono Mac I and Mono Mac 6, were isolated and both were assigned to the monocyte lineage on the basis of morphological, cytochemical and immunological criteria. Most importantly, the clones express NaF-sensitive non-specific-esterase, produce reactive oxygen and stain with MAb My4. Mono Mac 6, in addition, constitutively exhibits phagocytosis of antibody-coated erythrocytes in 80% of the cells and reacts with a panel of MAbs that are specific for mature monocytes, i.e., M42, LeuM3, 63D3, Mo2 and UCHMI. By contrast, the monoblastic cell lines U937 and THP-I are negative for all these markers. Only expression of My4 could be detected after differentiation induced by interferon-gamma (IFN-gamma). Similar treatment of Mono Mac I, however, resulted in staining with all the monocyte-specific MAbs mentioned above, while IFN-gamma treatment of Mono Mac 6 enhanced antigen expression. In addition, the cells showed an increased frequency of multinucleated cells with a rise from 4.8% to 21.9%. Mono Mac 6 appears to be the only one of the cell lines studied to constitutively express phenotypic and functional features of mature monocytes. @@ -30286,7 +29063,6 @@ http://humupd.oxfordjournals.org/content/13/2/103.full - established from the peripheral blood of a 57-year-old man with acute myeloid leukemia (AML FAB M4) at diagnosis in 1987; cells carry an NPM1 gene mutation (type A) and the DNMT3A R882C mutation. http://www.dsmz.de/catalogues/details/culture/ACC-582.html?tx_dsmzresources_pi5%5BreturnPid%5D=192 @@ -30333,7 +29109,7 @@ http://humupd.oxfordjournals.org/content/13/2/103.full - + Human gastric cancer cell line (SGC-7901) was established by Wang Long-Bao et al in cooperation with Shanghai No.6 People's hospital and other institutions in China. The cells were isolated from surgically resected metastatic lymph node from a female patient with stage 4 gastric cancer with remarkable peritoneal invasion. The shape was Borrman stage 3-4. Long-Bao et al (1993) Recent Advances in Management of Digestive Cancers, pp 416-418 SGC-7901 @@ -30509,7 +29285,6 @@ http://humupd.oxfordjournals.org/content/13/2/103.full - Cell line was established from a patient with essential thrombocytosis that transformed into acute leukemia. The patient's initial clinical presentation included skin and lymph node infiltrations that were taken for an angiosarcoma due to positivity for CD34, CD31, and von Willebrand factor on immunohistology. In addition to hematopoietic markers, leukemic cells expressed endothelial antigens such as CD62E, CD105, and bound Ulex europäeus lectin-1. Immunocytochemistry revealed positive staining for vascular endothelial growth factor receptor type 2 (KDR), Tie-2/Tek, the angiopoietin receptor, and vascular endothelial cadherin. These results were confirmed by PCR analysis. Simultaneous staining for CD62E and FISH analysis showed that cells with endothelial characteristics belonged to the leukemia. FISH analysis of histologic sections of the lymph node infiltration confirmed this manifestation as part of the leukemic process. The derived cell line, UKE-1, forms colonies in soft agar and is tumorigenic in SCID mice. Fiedler et al (2000) Cancer 88:344-351 @@ -30634,6 +29409,7 @@ http://humupd.oxfordjournals.org/content/13/2/103.full + The blood pressure during the contraction of the left ventricle of the heart. Dani Welter @@ -30652,6 +29428,7 @@ http://humupd.oxfordjournals.org/content/13/2/103.full + The blood pressure after the contraction of the heart while the chambers of the heart refill with blood. Dani Welter @@ -30670,6 +29447,7 @@ http://humupd.oxfordjournals.org/content/13/2/103.full + The mean pressure of the blood within the arterial circulation. The arterial pressure may be directly measured by insertion of an intra-arterial catheter connected to a transducer. The mean arterial pressure (MAP) can be calculated by subsequent analysis of the waveform. MAP can be approximated without an invasive procedure using the following formula: diastolic pressure plus 1/3 of the pulse pressure, where pulse pressure is systolic pressure - diastolic pressure. Dani Welter @@ -31692,9 +30470,15 @@ http://humupd.oxfordjournals.org/content/13/2/103.full + Human lung adenocarcinoma cell line from 52-year-old Asian female patient + Dani Welter http://www.utsouthwestern.edu/about-us/administrative-offices/technology-development/industry/human-cancer-cell-lines.html + PMID:10353731 + PMID:20679594 + PMID:25485619 + HCC-2279 HCC2279 @@ -32185,7 +30969,6 @@ http://humupd.oxfordjournals.org/content/13/2/103.full - Human acute myeloid leukemia cell line established from the peripheral blood of a 24-year-old man with refractory acute promyelocytic leukemia after mediastinal granulocytic sarcoma. (DSMZ catalog number ACC 536) http://www.dsmz.de/catalogues/details/culture/ACC-536.html @@ -32415,22 +31198,6 @@ http://humupd.oxfordjournals.org/content/13/2/103.full - - - - - - - Human anaplastic large T cell lymphoma cell line established from the pleural effusion an 11-year-old boy with CD30+ (Ki-1) large T cell lymphoma in 1983 (also described as "SR"); described to express the NPM1-ALK (NPM-ALK) fusion gene (DSMZ catalog number ACC 369) - http://www.dsmz.de/catalogues/details/culture/ACC-369.html - BTO:0003585 - CLO:0009126 - RRID:CVCL_1711 - SR-786 - - - - @@ -32860,7 +31627,6 @@ her lifetime - mouse multiple myeloma cell line @@ -33152,7 +31918,6 @@ her lifetime - human myeloma cell line derived from a peritoneal effusion of a patient with refractory myeloma @@ -33411,7 +32176,6 @@ her lifetime - human multiple myeloma cell line established from the peritoneal fluid of a 58-year-old woman with IgG lambda myeloma in 1988 at her terminal refractory stage (DSMZ catalog number ACC 560) @@ -33516,7 +32280,6 @@ her lifetime - Human erythroleukemia, established from the peripheral blood of a 30-year-old man with erythroleukemia (AML M6) in relapse (after treatment for Hodgkin's disease) in 1980; cells were described to be capable of spontaneous and induced globin synthesis @@ -33558,17 +32321,9 @@ her lifetime human gastric carcinoma cell line established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histologically as undifferentiated carcinoma Laura Huerta - BTO:0004828 - CLO:0003739 - RRID:CVCL_1279 + http://www.sigmaaldrich.com/catalog/product/sigma/94042256?lang=en&region=GB HGC-27 - - - - human gastric carcinoma cell line established by culture of the metastatic lymph node from a gastric cancer patient diagnosed histologically as undifferentiated carcinoma - http://www.sigmaaldrich.com/catalog/product/sigma/94042256?lang=en&region=GB - @@ -33590,7 +32345,6 @@ her lifetime - human acute myeloid leukemia cell line established in 1994 from the peripheral blood of a 47-year-old woman with acute myeloid leukemia (AML FAB M4) secondary to previous myelodysplastic syndromes (MDS), specifically chronic myelomonocytic leukemia (CMML) (DSMZ catalog number ACC-600) @@ -33950,7 +32704,6 @@ her lifetime - human acute myeloid leukemia cell line established from the peripheral blood of a 7-year-old Japanese boy with acute myeloid leukemia (AML FAB M2) (in 2nd relapse after bone marrow transplantation) in 1989 (DSMZ catalog number AAC 2200 @@ -33983,7 +32736,6 @@ her lifetime - human multiple myeloma cell line established from a pleural effusion of a 53 year old man with IgA lambda multiple myeloma with hyperamylasemia @@ -34012,7 +32764,6 @@ her lifetime - human multiple myeloma cell line from a 62 year old Japanese male @@ -34027,7 +32778,6 @@ her lifetime - human multiple myeloma cell line established from the bone marrow of a 64-year-old woman with multiple myeloma in 1988 (DSMZ catalog number ACC 551) @@ -34046,7 +32796,6 @@ her lifetime - human multiple myeloma cell line established from the bone marrow of a 64-year-old woman with multiple myeloma in 1988 @@ -34061,7 +32810,6 @@ her lifetime - human multiple myeloma cell line from a 62 year old Japanese male @@ -34076,7 +32824,6 @@ her lifetime - human multiple myeloma cell line from a 50 year old Japanese male @@ -34091,7 +32838,6 @@ her lifetime - human multiple myeloma cell line from a 52 year old Japanese male @@ -34106,7 +32852,6 @@ her lifetime - human multiple myeloma cell line from a 77 year old female @@ -34121,7 +32866,6 @@ her lifetime - human multiple myeloma cell line from a 77 year old Japanese female @@ -34136,7 +32880,6 @@ her lifetime - human multiple myeloma cell line from a 60 year old Japanese female @@ -34278,8 +33021,6 @@ her lifetime human esophageal squamous carcinoma cell line established from the well differentiated esophageal squamous cell carcinoma resected from middle intra-thoracic esophagus of a 53-year-old Japanese man prior to treatment (DSMZ catalog number ACC 379) Laura Huerta http://www.dsmz.de/catalogues/details/culture/ACC-379.html?tx_dsmzresources_pi5%5BreturnPid%5D=192 - CLO:0007130 - RRID:CVCL_1349 KYSE-180 @@ -34536,7 +33277,6 @@ her lifetime - human acute myeloid leukemia cell line established from the peripheral blood of a 40-year-old Japanese man with acute myeloid leukemia (AML) FAB M4eo at second relapse in 1988 (DSMZ catalog number ACC 357) @@ -34639,7 +33379,6 @@ her lifetime - human acute myeloid leukemia cell line established in 1999 from the peripheral blood of a 77-year-old Japanese woman at relapse of acute myeloid leukemia (DSMZ catalog number ACC 555) @@ -34654,7 +33393,6 @@ her lifetime - human multiple myeloma cell line established from the peripheral blood of a 55-year-old man with IgD lambda type multiple myeloma in 1991 (DSMZ catalog number ACC 607) @@ -34669,7 +33407,6 @@ her lifetime - human multiple myeloma cell line established from the peripheral blood of a 52-year-old Japanese man with multiple myeloma (stage IIIA, type IgD lambda) in 2002 (DSMZ catalog number ACC 569) @@ -35446,7 +34183,6 @@ her lifetime - human acute myeloid leukemia cell line established from the peripheral blood of a 65-year-old man with acute myeloid leukemia (AML FAB M4) in 1986 (DSMZ catalog number ACC 99) @@ -35461,7 +34197,6 @@ her lifetime - human acute myeloid leukemia cell line established from the peripheral blood of a 77-year-old man with acute myeloid leukemia (AML M4) in relapse in 1990 (DSMZ catalog number ACC 247) @@ -35548,7 +34283,6 @@ her lifetime - human acute myeloid leukemia cell line established from erythroleukemia blasts (AML M6) of a 62-year-old patient following a 7-year chlorambucil treatment for chronic lymphocytic leukemia (DSMZ catalog number ACC 529) @@ -35563,7 +34297,6 @@ her lifetime - human acute myeloid leukemia cell line established in 1984 from the leukemic cells of a 56-year-old patient with erythroleukemia (DSMZ catalog number ACC 619) @@ -35606,7 +34339,6 @@ her lifetime - human multiple myeloma cell line established from the peripheral blood of a 56-year-old woman with multiple myeloma (IgG lambda) in leukemic phase (relapse, terminal) in 1982 (DSMZ catalog number ACC 50) @@ -35898,17 +34630,9 @@ her lifetime human pancreatic carcinoma cell line of islet cell origin Laura Huerta - BTO:0005500 - CLO:0037113 - RRID:CVCL_3143 + PMID: 25485619 QGP-1 - - - - human pancreatic carcinoma cell line of islet cell origin - PMID:25485619 - @@ -36041,7 +34765,6 @@ her lifetime - human acute myeloid leukemia cell line established in 1995 from the bone marrow of a 63-year-old man with acute myeloid leukemia of monocytic origin (DSMZ ACC 468) @@ -36072,7 +34795,6 @@ her lifetime - human myelodysplasic cell line established from the peripheral blood of a 76-year-old Japanese man with acute monoblastic leukemia (AML M5) in 1989 following myelodysplastic syndromes (DSMZ catalog number ACC 547) @@ -39299,9 +38021,15 @@ her lifetime HAP1 is a near-haploid human cell line that was derived from the male chronic myelogenous leukemia (CML) cell line KBM-7. HAP1 cells are adherent with fibroblast-like morphology. + Human chronic myelogenous leukemia cell line + Kalpana Panneerselvam + Zoe May Pendlington + 2024-02-14T16:54:54Z https://www.horizondiscovery.com/knowledge-base/faqs-hap1-knockout-cell-lines#B PMID:3466682 + RRID:CVCL_Y019 HAP1 + HAP1 HAP-1 @@ -40408,7 +39136,7 @@ her lifetime - + @@ -57984,7 +56712,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Joannella Morales true PMID:23823483 - adipic acid mesurement + adipic acid measurement @@ -58622,7 +57350,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Joannella Morales true PMID:23823483 - hypoxanthine mesurement + hypoxanthine measurement @@ -58885,7 +57613,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Joannella Morales true PMID:23823483 - pantothenic acid mesurement + pantothenic acid measurement @@ -62493,7 +61221,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Annalisa Buniello true PMID:33067605 - EGF epidermal growth factor measurement @@ -96268,7 +94995,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Normal human epidermal premalignant keratinocyte-derived cell line Kalpana Panneerselvam RRID:CVCL_M673 - scc12f2 + SCC12F2 @@ -96338,6 +95065,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var human glioblastoma primary tumor-derived line cell Kalpana Panneerselvam PMID:32320427 + RRID:CVCL_D7DP NZG0906 @@ -96546,13 +95274,12 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human megakaryoblastic cell line Kalpana Panneerselvam CLO:0009490 - ut7 cell + UT7 cell @@ -96563,25 +95290,10 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - ATM-/- fibroblast cell line GM9607 + ATM-/- fibroblast cell line GM09607 Kalpana Panneerselvam CLO:0026603 - gm9607 cell - - - - - - - - - - - Human SUM1315- metastatic/invasive breast ductal carcinoma cell line - Kalpana Panneerselvam - CLO:0009916 - RRID:CVCL_5589 - sum1315 + GM09607 cell @@ -96595,7 +95307,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Kalpana Panneerselvam CLO:0001138 RRID:CVCL_4688 - b5-589 cell + B5-589 cell @@ -96643,21 +95355,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - - - - - - - Human Hodgkin lymphoma L-428 cells - Kalpana Panneerselvam - CLO:0007189 - RRID:CVCL_1361 - L-428 cell - - - - @@ -96702,36 +95399,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - - - - - - - human hepatocellular carcinoma (HCC) cells (p53-null). - Kalpana Panneerselvam - CLO:0003710 - HEP-3B cell - - - - - - - - - - - - Epithelial cells derived from human breast tumour - Kalpana Panneerselvam - CLO:0009251 - RRID:CVCL_0553 - T-47D cell - - - - @@ -96816,26 +95483,10 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - - - - - - - Human with IEF of AST, LDH, NP established from the biopsy from a fibrosarcoma of a 35-year-old Caucasian man in 1972 - Kalpana Panneerselvam - CLO:0004276 - RRID:CVCL_0317 - HT-1080 cell - - - - - TF-1 have been derived from a patient with erythroleukaemia. They show complete growth dependency on GM-CSF or IL-3, and carry a homogeneous chromosomal abnormality (54,X). @@ -96852,7 +95503,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human acute monocytic leukemia cell line, established from a 13 years old gir @@ -97246,7 +95896,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - A subline of the M-07 human megakaryoblastic leukemia cell line @@ -97279,7 +95928,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - @@ -97449,7 +96097,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human acute myeloblastic leukaemia cell line from human peripheral blood @@ -97533,7 +96180,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human infant acute lymphoblastic leukemia cell line @@ -97566,7 +96212,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human acute myeloid leukemia cell line. Sister cell line of MOLM-13 cell @@ -97833,7 +96478,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human acute myeloid leukemia cell line; established from the bone marrow of a 31-year-old woman with acute myeloid leukemia at 2nd relapse @@ -97891,6 +96535,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Zoe May Pendlington 2024-02-14T14:49:04Z PMID:4300880 + RRID:CVCL_D7DR M426 @@ -98122,6 +96767,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Zoe May Pendlington 2024-02-14T15:52:36Z PMID:12411104 + RRID:CVCL_D7DX KN73 @@ -98131,7 +96777,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human monoclonal plasma cell line Kalpana Panneerselvam @@ -98304,7 +96949,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human acute myelomonocytic leukemia cell line with FLT3 ITD @@ -98329,6 +96973,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Zoe May Pendlington 2024-02-14T16:24:08Z PMID:35853885 + RRID:CVCL_D7EG EUFA1341 @@ -98454,7 +97099,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - Human acute promyelocytic leukemia Kalpana Panneerselvam @@ -98499,22 +97143,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - - - - - - - Human chronic myelogenous leukemia cell line - Kalpana Panneerselvam - Zoe May Pendlington - 2024-02-14T16:54:54Z - RRID:CVCL_Y019 - HAP1 - - - - @@ -98693,8 +97321,6 @@ of diseased coronary vessels at the time of a catheterization procedure. The var 2024-02-14T17:50:03Z BTO:0000773 PMID:3017841 - RRID:CVCL_4T75 - 1C1 LCL @@ -98794,6 +97420,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Zoe May Pendlington 2024-02-14T18:07:39Z PMID:22325559 + RRID:CVCL_D7E6 PAXC002 @@ -98878,6 +97505,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Zoe May Pendlington 2024-02-14T18:17:19Z PMID:30241395 + RRID:CVCL_D7EM WHCO6 @@ -99147,6 +97775,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Zoe May Pendlington 2024-02-14T18:40:24Z PMID:23065768 + RRID:CVCL_D7EN CLB-SAV @@ -99562,7 +98191,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human Fanconi anemia cell line Kalpana Panneerselvam CLO:0001907 @@ -99577,6 +98206,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human melanoma cell line Kalpana Panneerselvam BTO:0005717 @@ -99590,7 +98220,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human glioblastoma cell line Kalpana Panneerselvam RRID:CVCL_8565 @@ -99604,7 +98235,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human alveolar rhabdomyosarcoma cell line Kalpana Panneerselvam BTO:0005384 @@ -99619,6 +98251,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human Cystic fibrotic bronchial epithelial cell line Kalpana Panneerselvam @@ -99636,6 +98269,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human oral squamous cell carcinoma cell line Kalpana Panneerselvam RRID:CVCL_6782 @@ -99649,6 +98283,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human lymphoblastoid cell line Kalpana Panneerselvam @@ -99665,6 +98300,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human osteosarcoma cell line Kalpana Panneerselvam RRID:CVCL_4V80 @@ -99677,7 +98313,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human adult T cell lymphoma cell line Kalpana Panneerselvam RRID:CVCL_0G05 @@ -99690,7 +98327,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human nasopharyngeal carcinoma cell line Kalpana Panneerselvam RRID:CVCL_M597 @@ -99704,7 +98342,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human astrocytoma cell line Kalpana Panneerselvam RRID:CVCL_A758 @@ -99734,6 +98373,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human papillary thyroid carcinoma cell line Kalpana Panneerselvam BTO:0006508 @@ -99747,7 +98387,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human hybrid cardiomyocyte Kalpana Panneerselvam RRID:CVCL_4U18 @@ -99756,26 +98397,12 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - - - - - - Human ovarian endometrioid adenocarcinoma - Kalpana Panneerselvam - CLO:0051452 - RRID:CVCL_3770 - OVK18 - RCB1903 cell - - - - - + + Human transformed human fetal lung cell line Kalpana Panneerselvam RRID:CVCL_BT02 @@ -99788,7 +98415,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human immortalized corneal fibroblast Kalpana Panneerselvam RRID:CVCL_6E30 @@ -99802,6 +98429,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human oral squamous cell carcinoma cell line Kalpana Panneerselvam RRID:CVCL_2458 @@ -99814,6 +98442,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + EBV-transformed human lymphoblastoid cell line Kalpana Panneerselvam @@ -99828,6 +98457,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human colorectal cancer cell line Kalpana Panneerselvam RRID:CVCL_A604 @@ -99842,7 +98472,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human invasive breast carcinoma Kalpana Panneerselvam RRID:CVCL_GY01 @@ -99855,7 +98486,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human endometrial carcinoma cell line Kalpana Panneerselvam RRID:CVCL_IW37 @@ -99868,7 +98500,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human hybrid cell line that express phenotypic characteristics of primary oligodendrocytes Kalpana Panneerselvam RRID:CVCL_D357 @@ -99881,6 +98513,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human B-lymphoblastoid cell line Kalpana Panneerselvam @@ -99894,6 +98527,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human B-lymphoblastoid cell line Kalpana Panneerselvam @@ -99908,6 +98542,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human B-lymphoblastoid cell line Kalpana Panneerselvam @@ -99921,7 +98556,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human pancreatic neuroendocrine tumor cell line Kalpana Panneerselvam BTO:0003856 @@ -99935,7 +98571,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human hepatocyte cell line Kalpana Panneerselvam RRID:CVCL_RW59 @@ -99949,6 +98586,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + + Human prostate carcinoma cell line Kalpana Panneerselvam RRID:CVCL_4833 @@ -99961,7 +98600,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human embryonic retinoblasts Kalpana Panneerselvam RRID:CVCL_1K15 @@ -99974,7 +98613,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Immortalized human chondrocyte cell line Kalpana Panneerselvam BTO:0003859 @@ -99990,7 +98629,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Highly metastatic variant from human transitional cell carcinoma Kalpana Panneerselvam BTO:0004894 @@ -100005,7 +98645,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human natural killer cell leukemia Kalpana Panneerselvam RRID:CVCL_2976 @@ -100019,7 +98660,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human oral squamous cell carcinoma cell line Kalpana Panneerselvam RRID:CVCL_2229 @@ -100033,7 +98675,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human immortalized kidney epithelial cell line Kalpana Panneerselvam RRID:CVCL_0344 @@ -100046,6 +98688,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human lymphoblastoid cell line Kalpana Panneerselvam @@ -100060,7 +98703,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human breast epithelial cell line Kalpana Panneerselvam BTO:0003886 @@ -100075,7 +98719,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human myxoid liposarcoma cell line Kalpana Panneerselvam RRID:CVCL_S816 @@ -100089,7 +98734,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human myxoid liposarcoma cell line Kalpana Panneerselvam RRID:CVCL_S813 @@ -100119,6 +98765,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human B-lymphoblastoid cell line Kalpana Panneerselvam @@ -100133,7 +98780,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human esophageal squamous cell carcinoma cell line Kalpana Panneerselvam BTO:0004601 @@ -100149,6 +98797,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human eosinophilic leukaemia cell line Kalpana Panneerselvam @@ -100166,6 +98815,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human lymphoblastoid cell line Kalpana Panneerselvam @@ -100179,6 +98829,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human lymphoblastoid cell line Kalpana Panneerselvam @@ -100193,6 +98844,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human fibroblast cell line Kalpana Panneerselvam RRID:CVCL_RW39 @@ -100205,7 +98857,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human hepatocellular carcinoma cell line Kalpana Panneerselvam BTO:0005725 @@ -100221,6 +98874,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human colorectal cancer cell line Kalpana Panneerselvam CLO:0050628 @@ -100236,7 +98890,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human glioma cell line Kalpana Panneerselvam BTO:0002824 @@ -100251,6 +98906,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + HeLa derived cell line Kalpana Panneerselvam CLO:0003692 @@ -100264,7 +98920,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + immortal human esophagus-derived cell line Kalpana Panneerselvam CLO:0051372 @@ -100279,7 +98936,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human ovarian carcinoma cell line Kalpana Panneerselvam RRID:CVCL_4377 @@ -100294,6 +98952,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human cell line derived from thyroid cancer. Poorly differentiated papillary adenocarcinoma Kalpana Panneerselvam CLO:0050951 @@ -100309,7 +98968,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human anaplastic astrocytoma cell line Kalpana Panneerselvam RRID:CVCL_8563 @@ -100323,7 +98983,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human glioblastoma cell line Kalpana Panneerselvam RRID:CVCL_8564 @@ -100337,7 +98998,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human normal gastric epithelial cell line Kalpana Panneerselvam BTO:0006394 @@ -100351,7 +99012,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human amelanotic melanoma cell line Kalpana Panneerselvam RRID:CVCL_6284 @@ -100365,7 +99027,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human thyroid gland papillary carcinoma cell line Kalpana Panneerselvam RRID:CVCL_2537 @@ -100378,7 +99041,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + immortal human lung-derived cell line Kalpana Panneerselvam CLO:0037033 @@ -100394,6 +99058,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human anaplastic thyroid cancer cell line Kalpana Panneerselvam BTO:0001611 @@ -100407,7 +99072,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + High tumorigenic and metastatic subline of SUNE-1 cell line Kalpana Panneerselvam BTO:0006010 @@ -100424,7 +99089,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human hepatocellular carcinoma cell line Kalpana Panneerselvam BTO:0004469 @@ -100441,6 +99107,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human salivary gland adenoid cystic carcinoma Kalpana Panneerselvam RRID:CVCL_H589 @@ -100453,7 +99120,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human-human somatic cell hybrid cell line, established by PEG-mediated fusion of the B-lymphoblastoid cell line LCL 721.174 with an 8-azaguanine and ouabain-resistant variant of the T-LCL CEM. Subclone of the T1 cell line which has lost both CEM(R)-derived copies of chromosome 6 Kalpana Panneerselvam @@ -100470,6 +99137,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human retinoblastoma cell line Kalpana Panneerselvam RRID:CVCL_D543 @@ -100482,7 +99150,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + T-REx cell derivative with targeted integration of a Flp-In expression vector Kalpana Panneerselvam BTO:0006149 @@ -100496,6 +99165,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human papillomavirus-related cervical adenocarcinoma Kalpana Panneerselvam @@ -100509,7 +99179,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human chondrocyte cell line Kalpana Panneerselvam BTO:0003860 @@ -100528,7 +99198,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + transformed human retinoblast cell line Kalpana Panneerselvam RRID:CVCL_G704 @@ -100541,7 +99211,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line Kalpana Panneerselvam RRID:CVCL_A785 @@ -100555,6 +99226,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human duodenal adenocarcinoma cell line Kalpana Panneerselvam CLO:0009964 @@ -100570,6 +99242,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human neuroblastoma cell line Kalpana Panneerselvam @@ -100585,7 +99258,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human ovarian serous adenocarcinoma cell line Kalpana Panneerselvam CLO:0003406 @@ -100599,7 +99273,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human acute lymphoblastic leukemia cell line Kalpana Panneerselvam BTO:0001969 @@ -100615,6 +99290,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human benign prostate hyperplasia; prostate epithelial cells from a 68-year-old man with benign prostate hyperplasia; cells were immortalized with SV-40 large T-antigen; cells were described to express cytokeratins 8, 18, and 19 (but not 14) and to metabolize prostatic androgens Kalpana Panneerselvam BTO:0001323 @@ -100629,6 +99305,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human neuroblastoma cell line Kalpana Panneerselvam @@ -100644,7 +99321,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human esophageal cell line; derived in 1986 from human esophageal autopsy tissue by transfection with plasmid pRSV-T consisting of the RSV-LTR promoter and the sequence encoding the simian virus 40 large T-antigen Kalpana Panneerselvam BTO:0004433 @@ -100659,7 +99336,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human acute myeloid leukemia cell line; established from the peripheral blood of a 20-year-old man with acute myeloid leukemia AML FAB M5a at relapse in 1995 after initial myelodysplastic syndromes Kalpana Panneerselvam BTO:0004175 @@ -100674,7 +99352,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + The 2fTGH-U6A Cell Line is part of a panel of IFNy pathway mutant fibrosarcoma cell lines isolated by chemical mutagenesis of IFNy insensitive reporter cells derived from HT1080 cells. Kalpana Panneerselvam RRID:CVCL_D316 @@ -100688,7 +99367,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Immortalized human vascular smooth muscle cells Kalpana Panneerselvam PMID: 10764661 @@ -100702,7 +99381,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + A transformed human kidney 293 cell line stably expressing an SV40 temperature-sensitive T antigen Kalpana Panneerselvam BTO:0004232 @@ -100717,6 +99397,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + XPCS2BA; also has features of Cockayne syndrome; no evidence of malignancy; bilateral sensorineural hearing loss; dry skin; numerous freckles; hyperpigmented macules; broad-based choreoathetotic gait; brother of GM13025; donor subject is homozygous for a T>C transversion in the ERCC3 gene which results in a phenylalanine-99-to-serine missense mutation [PHE99SER (F99S)]. Kalpana Panneerselvam CLO:0013998 @@ -100731,7 +99412,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + RAO-3 was established by transduction of the Q61L mutant RAS into human mammary epithelial cells that were immortalized with catalytic subunit of telomerase (hTERT) Kalpana Panneerselvam PMID: 16395697 @@ -100745,7 +99427,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human Ewing Sarcoma cell line Kalpana Panneerselvam CLO:0009873 @@ -100760,7 +99443,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human invasive breast carcinoma Kalpana Panneerselvam PMID: 11479214 @@ -100774,7 +99458,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human cystadenocarcinoma cell line Kalpana Panneerselvam BTO:0003792 @@ -100790,6 +99475,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human oral squamous cell carcinoma cell line Kalpana Panneerselvam BTO:0002025 @@ -100805,6 +99491,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Nonmalignant human colonic epithelial cell line Kalpana Panneerselvam BTO:0004306 @@ -100818,7 +99505,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human glioblastoma cell line Kalpana Panneerselvam PMID: 26629530 @@ -100833,7 +99521,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human glioblastoma cell line Kalpana Panneerselvam PMID: 26629530 @@ -100848,7 +99537,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Clonal derivative from HCT116 colorectal carcinoma cell line, that lacks the mutant k-ras allele Kalpana Panneerselvam BTO:0003469 @@ -100875,7 +99565,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human hepatocellular carcinoma cell line Kalpana Panneerselvam BTO:0004471 @@ -100889,7 +99580,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Immortalized human hepatic stellate cell line Kalpana Panneerselvam BTO:0003516 @@ -100903,7 +99595,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human glioblastoma cell line Kalpana Panneerselvam BTO:0002216 @@ -100917,7 +99610,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Human thyroid follicular epithelial cell line Kalpana Panneerselvam BTO:0004859 @@ -100932,7 +99625,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human glioblastoma cell line Kalpana Panneerselvam BTO:0004457 @@ -100948,6 +99642,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human intestinal epithelial cell line Kalpana Panneerselvam BTO:0005068 @@ -100976,6 +99671,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human thyroid carcinoma cell line, established from the primary tumor of a 67-year-old woman with primary thyroid undifferentiated carcinoma Kalpana Panneerselvam BTO:0000919 @@ -100989,7 +99685,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human testicular seminoma cell line Kalpana Panneerselvam PMID: 8394948 @@ -101003,7 +99700,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Human rhabdomyosarcoma cell line Kalpana Panneerselvam CLO:0037075 @@ -101019,6 +99717,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Human melanoma cell line Kalpana Panneerselvam BTO:0001588 @@ -101029,37 +99728,11 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - - - - - - A DNA packaging complex comprised of approximately 200 base pairs of DNA wound around a protein core, which is formed by an octomer of histones. The histone octomer includes two dimers of histones H2A and H2B that surround a tetramer consisting of two molecules of histone H3 and two molecules of histone H4 - Kalpana Panneerselvam - GO:0000786 - NCIT:C13268 - Nucleosome - - - - - - - - - - Fluid shear stress is the force acting on an object in a system where the fluid is moving across a solid surface. - Kalpana Panneerselvam - fluid shear stress - - - - - + Mouse spermatocyte cell line, established by stable cotransfection of freshly isolated spermatocytes with the SV40 large T antigen gene and a temperature sensitive mutant of the p53 tumor suppressor gene Kalpana Panneerselvam BTO:0006500 @@ -101108,6 +99781,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + immortal mouse fibroblast cell line cell that was derived from some fibroblasts from a C3H/An mouse connective tissue Kalpana Panneerselvam CLO:0007351 @@ -101138,7 +99812,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Rat liver cell line. Established from the buffalo strain of rattus norvegicus Kalpana Panneerselvam BTO:0000154 @@ -101153,7 +99827,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + NIH-3T3 cell line stably transfected with insulin receptor cDNA Kalpana Panneerselvam BTO:0004245 @@ -101169,6 +99844,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rattus norvegicus connective tissue fibroblast cell line Kalpana Panneerselvam BTO:0003293 @@ -101183,7 +99859,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + HER 14 cells are NIH 3T3 fibroblasts devoid of endogenous EGF-R, transfected with the human EGF-R cDNA Kalpana Panneerselvam BTO:0005263 @@ -101199,7 +99875,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + NIH-3T3 cell line stably transfected with EGFR Kalpana Panneerselvam CLO:0008170 @@ -101250,6 +99926,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse monocytes-macrophages, established from a tumor in a female BALB/c mouse in 1968; cells were described to synthesize lysozyme and interleukin-1 and to have receptors for immunoglobulin and complement Kalpana Panneerselvam CLO:0007005 @@ -101265,6 +99942,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse T-lymphocyte lymphoma cell line, established from a lymphoma induced in a C57BL mouse by 9,10-dimethyl-1,2-benzanthracene. Kalpana Panneerselvam @@ -101281,7 +99959,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Lymphoma cell line, established from mus musculus DBA/2. Tumors develop within 21 days at 100% frequency in nude mice inoculated subcutaneously with 10(7) cells. Kalpana Panneerselvam CLO:0008326 @@ -101298,6 +99977,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat hepatoma cell line. Derived from a rat ascites tumour, which in turn was derived from a solid hepatoma induced in male Buffalo rats by feeding them 0.04% N,N'-2,7fluorenyle-bis-2,2,2-trifluoroacetamide for 12.4 months Kalpana Panneerselvam @@ -101313,7 +99993,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse bone marrow cell line, established from the long-term bone marrow culture of B6D2F1 mice; cells are IL-3-dependent; their differentiation is blocked; this subclone is responsive to G-CSF Kalpana Panneerselvam CLO:0003073 @@ -101329,6 +100009,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mus musculus (mouse) brain; neuroblast; neuroblastoma cell line. The N1E-115 cell line was established in 1971 by T. Amano, E. Richelson, and M. Nirenberg by cloning the C-1300 spontaneous mouse neuroblastoma tumor, C-1300 Kalpana Panneerselvam @@ -101344,7 +100025,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + A immortal mouse cell line cell that has the characteristics: IL-3 dependent mouse myeloid cells. MoLV induced. Kalpana Panneerselvam CLO:0050174 @@ -101469,7 +100151,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse pro B cell line. IL-3 dependent murine pro B cell line established from peripheral blood; apparently derived from BALB/c mouse. Kalpana Panneerselvam CLO:0051421 @@ -101486,6 +100168,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat, liver, hepatoma, H-35 Reuber cell line. Kalpana Panneerselvam @@ -101502,7 +100185,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Normal rat thyroid cell line Kalpana Panneerselvam BTO:0003800 @@ -101517,6 +100200,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Murine lung epithelial cell line Kalpana Panneerselvam BTO:0005242 @@ -101560,7 +100244,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse bone marrow cell line Kalpana Panneerselvam CLO:0051042 @@ -101580,6 +100264,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mus musculus (mouse) brain neuroblastoma cell line. Clone Neuro-2a was established by R.J. Klebe and F.H. Ruddle from a spontaneous tumor of a strain A albino mouse Kalpana Panneerselvam @@ -101600,6 +100285,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + This cell line was derived in 1996 from a heterogeneous 32 week primary tumor in the prostate of a PB-Tag C57BL/6 (TRAMP) mouse. Kalpana Panneerselvam BTO:0005112 @@ -101614,6 +100300,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse epithelial-like hepatoma cell line derived from a primary hepatocyte culture from the livers of 6 week old female BALB/c mice Kalpana Panneerselvam @@ -101630,6 +100317,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse skin melanoma cell line from mouse strain C57BL/6 Kalpana Panneerselvam BTO:0002014 @@ -101661,6 +100349,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat adrenal gland pheochromocytoma cell line Kalpana Panneerselvam RRID:CVCL_JX88 @@ -101674,6 +100363,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat kidney epithelial-like cells. Cell line was cloned from a mixed culture of normal rat kidney cells as was NRK-49F the two cell lines were described to be distinct in growth properties and in transforming abilities; NRK-52E is supposed to be much more stable. Kalpana Panneerselvam BTO:0002408 @@ -101688,7 +100378,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse hybridoma cell line Kalpana Panneerselvam RRID:CVCL_C7R9 @@ -101701,7 +100391,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Rat insulin- and somatostatin-secreting cell line Kalpana Panneerselvam CLO:0008818 @@ -101716,6 +100407,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rabbit renal epithelium cell line Kalpana Panneerselvam CLO:0008822 @@ -101734,7 +100426,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + A immortal mouse skin-derived cell line cell that has the characteristics: Mouse melanoma producing melanin Kalpana Panneerselvam CLO:0050752 @@ -101750,6 +100443,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rattus norvegicus skeletal muscle myoblast cell line. The L6 myogenic line was isolated from primary cultures of rat thigh muscle maintained for the first two passages in the presence of methyl cholanthrene. Kalpana Panneerselvam BTO:0002809 @@ -101764,7 +100458,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Rat liver-derived cell line Kalpana Panneerselvam CLO:0003603 @@ -101778,6 +100473,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + + Mouse, (C57BL/6xDBA/2)F1, blood, leukemia, pre-B cell line. Kalpana Panneerselvam @@ -101793,6 +100490,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat embryo fibroblast cell line Kalpana Panneerselvam @@ -101822,7 +100520,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse erythroid cell line Kalpana Panneerselvam RRID:CVCL_0355 @@ -101836,7 +100534,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse erythroid cell line Kalpana Panneerselvam RRID:CVCL_6000 @@ -101849,7 +100547,9 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + + Mouse embryonal carcinoma cell line, established from the teratocarcinoma induced in a C3H/He strain mouse. Kalpana Panneerselvam CLO:0008302 @@ -101865,7 +100565,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + T cell hybridoma cell line that specifically expresses high levels of HDAC7, a class IIa histone deacetylase. Kalpana Panneerselvam BTO:0004333 @@ -101879,7 +100579,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Mouse sarcoma cell line, from an adult mus musculus; Highly malignant mouse sarcoma cells, often passaged in ascites form. Kalpana Panneerselvam BTO:0001197 @@ -101894,7 +100595,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Mouse pituitary tumor cell line. Morphology: small rounded cells Kalpana Panneerselvam CLO:0001766 @@ -101910,7 +100612,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Rat, nervous system, immature, Schwann cell derived cell lin Kalpana Panneerselvam BTO:0001205 @@ -101921,29 +100624,11 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - - - - - - The glial cell strain, C6, was cloned from a rat glial tumor induced by N-nitrosomethylurea by Benda et al after a series of alternate culture and animal passages. Tissue: brain; glial cell; glioma. Morphology: fibroblast - Kalpana Panneerselvam - CLO:0002140 - CLO:0051387 - BTO:0000529 - CLO:0002072 - RRID:CVCL_0194 - RCB2854 - RGC6 - C6 glioma cell - - - - + This line was derived from the a 5-bromo-2'-deoxyuridine resistant strain of the Fischer rat fibroblast 3T3 like cell line, Rat1. Rat2 lacks detectable nuclear thymidine kinase, is highly transfectable by exogenous DNA and is phenotypically normal. Kalpana Panneerselvam @@ -101960,6 +100645,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Liver, hepatoma; Morris hepatoma 7777 cell line, established from a rattus norvegicus female. Kalpana Panneerselvam @@ -101996,6 +100682,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat hepatoma cell line. Kalpana Panneerselvam @@ -102009,6 +100696,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + The 3T6 cell line is a collagen and hyaluronic acid secreting line established by G. Todaro and H. Green in 1963 from disaggregated Swiss mouse embryos Kalpana Panneerselvam @@ -102025,7 +100713,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Rat schwannoma cell line. Kalpana Panneerselvam RRID:CVCL_JK04 @@ -102038,7 +100727,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Rat schwannoma cell line, in which merlin can be expressed from a stably transfected ectopic, doxycycline-inducible (TetON) construct. Kalpana Panneerselvam PMID: 16537381 @@ -102051,7 +100741,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Mouse megakaryoblastic cell line Kalpana Panneerselvam RRID:CVCL_E074 @@ -102078,7 +100769,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + FL5.12 cells are a murine pro-B-cell line derived from fetal liver, which undergo apoptotic cell death following IL-3 deprivation. Kalpana Panneerselvam BTO:0003328 @@ -102092,7 +100783,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse hybridoma cell line Kalpana Panneerselvam RRID:CVCL_A2IR @@ -102119,7 +100810,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Murine microglial cell line. Kalpana Panneerselvam BTO:0003350 @@ -102133,7 +100824,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse vascular endothelial cell line. SVEC4-10 is an endothelial cell line derived by SV40 (strain 4A) transformation of endothelial cells from axillary lymph node vessels. Kalpana Panneerselvam BTO:0002826 @@ -102175,7 +100866,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse bone marrow cell line; established from long-term bone marrow cultures of C3H/HeJ mice infected with the Friend murine leukemia virus. Kalpana Panneerselvam CLO:0001296 @@ -102221,6 +100912,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse mammary gland tumor epithelial cell line. Kalpana Panneerselvam RRID:CVCL_EG11 @@ -102234,6 +100926,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Normal mouse mammary epithelial cell line. Kalpana Panneerselvam BTO:0004183 @@ -102268,6 +100961,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse cloned growth factor dependent macrophage cell line Kalpana Panneerselvam RRID:CVCL_6771 @@ -102280,7 +100974,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse embryonic stem cell Kalpana Panneerselvam RRID:CVCL_7264 @@ -102307,7 +101001,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse brown adipocyte cell line Kalpana Panneerselvam RRID:CVCL_S893 @@ -102321,6 +101015,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + The UMR-106 cell line is a clonal derivative of a transplantable rat osteosarcoma that had been induced by injection of radiophosphorous (32P) Kalpana Panneerselvam BTO:0002576 @@ -102336,6 +101031,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + + Rat mammary adenocarcinoma cell line Kalpana Panneerselvam RRID:CVCL_8136 @@ -102348,7 +101045,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Cell line, derived from a brown fat tumor of a transgenic mouse, capable of expressing the brown fat-specific mitochondrial uncoupling protein. Kalpana Panneerselvam BTO:0005964 @@ -102363,6 +101060,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat osteosarcoma cell line. Kalpana Panneerselvam BTO:0002648 @@ -102376,7 +101074,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Kalpana Panneerselvam RRID:CVCL_C4BN B1-8 @@ -102405,7 +101103,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Kalpana Panneerselvam CLO:0009169 RRID:CVCL_6454 @@ -102436,6 +101134,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rattus norvegicus (rat), tumor cell line of exocrine pancreas Kalpana Panneerselvam BTO:0001928 @@ -102446,11 +101145,25 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + + + + + + Mouse immortal cell line cell + Kalpana Panneerselvam + CLO:0001701 + RRID:CVCL_4103 + AKR-2B + + + + - + Rat immortalized neuronal cell line Kalpana Panneerselvam RRID:CVCL_0E00 @@ -102463,7 +101176,9 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + + immortal mouse embryo-derived cell line cell Kalpana Panneerselvam CLO:0008424 @@ -102477,7 +101192,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Mouse myeloma cell line Kalpana Panneerselvam CLO:0008206 @@ -102494,7 +101210,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Mouse pituitary tumor cell line Kalpana Panneerselvam BTO:0003566 @@ -102508,7 +101224,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + immortal rat brain-derived cell line cell Kalpana Panneerselvam CLO:0001783 @@ -102522,7 +101239,8 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + + Mouse skin melanoma cell line, established from C57BL/6J mouse strain. Kalpana Panneerselvam CLO:0050764 @@ -102556,6 +101274,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Murine mammary tumor line from a female mus musculus Kalpana Panneerselvam CLO:0050955 @@ -102646,6 +101365,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse mammary epithelial cell line Kalpana Panneerselvam RRID:CVCL_5731 @@ -102660,7 +101380,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + Murine dendritic cell line Kalpana Panneerselvam RRID:CVCL_J409 @@ -102674,6 +101394,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Rat embryo cell line Kalpana Panneerselvam RRID:CVCL_6C52 @@ -102699,6 +101420,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + Mouse hepatoma cell line; derived from the BW7756 tumor that arose in a C57L mouse Kalpana Panneerselvam @@ -102712,6 +101434,18 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + + + + + + Kalpana Panneerselvam + RRID:CVCL_0300 + HIRc-B + + + + @@ -102725,31 +101459,47 @@ of diseased coronary vessels at the time of a catheterization procedure. The var - + - - - RCH-ACV cell line is a human B cell precursor leukemia cell line established from a bone marrow sample of a child with acute lymphoblastic leukemia. - paola - RCH - BTO:0003376 - RCHACV - RCH-ACV + + + An immortalized human erythroid progenitor cell line. + Zoe May Pendlington + 2024-08-07T12:56:51Z + RRID:CVCL_VI06 + HUDEP2 + Human Umbilical cord blood-Derived Erythroid Progenitor-2 + HUDEP-2 - + - RCH-ACV cell line is a human B cell precursor leukemia cell line established from a bone marrow sample of a child with acute lymphoblastic leukemia. - PMID:3455845 + An immortalized human erythroid progenitor cell line. + PMID:23533656 + + + + + + It is the most common clonal somatic alteration in leukocytes of female individuals. + Zoe May Pendlington + 2024-08-14T09:43:25Z + mLOX + mosaic loss of chromosome X measurement + + + + + BLaER1 cell line is a tamoxifen-inducible subclone of the RCH-ACV B-cell leukemia cell line genetically modified using a retrovirus vector to express C/EBPα fused with the estrogen receptor hormone binding domain (ER) and GFP. paola @@ -151138,7 +149888,7 @@ of diseased coronary vessels at the time of a catheterization procedure. The var Quantification of visual masking, a phenomenon of visual perception which occurs when the visibility of one image, called a target, is reduced by the presence of another, called a mask. Timing arrangements include forward masking, backward masking, and simultaneous masking. Spatial arrangements include pattern masking and metacontrast. Visual masking deficits are potential schizophrenia endophenotypes. true - visual masking mesurement + visual masking measurement @@ -156249,6 +154999,283 @@ of diseased coronary vessels at the time of a catheterization procedure. The var + + + + + + Quantification of one or more antibodies to the hepatitis E virus in a sample. + PMID:37664632 + anti-HEV antibody measurement + To be reviewed for replacement with OBA term. + anti-hepatitis E virus antibody measurement + + + + + + + + + + Quantification of one or more antibodies to the superantigen toxic shock syndrome toxin-1 (TSST-1) produced by Staphylococcus aureus in a sample. + PMID:37731490 + To be reviewed for replacement with OBA term. + anti-TSST-1 antibody measurement + + + + + + + + + + Quantification of one or more antibodies to the hepatitis B virus anitgen in a sample. + PMID:38626723 + anti-HBV antibody measurement + To be reviewed for replacement with OBA term. + anti-hepatitis B virus antibody measurement + + + + + + + + + + + + + + + example to be eventually removed + example to be eventually removed + + + + + + + + + failed exploratory term + The term was used in an attempt to structure part of the ontology but in retrospect failed to do a good job + Person:Alan Ruttenberg + failed exploratory term + + + + + + + + + metadata complete + Class has all its metadata, but is either not guaranteed to be in its final location in the asserted IS_A hierarchy or refers to another class that is not complete. + metadata complete + + + + + + + + + organizational term + Term created to ease viewing/sort terms for development purpose, and will not be included in a release + organizational term + + + + + + + + + ready for release + Class has undergone final review, is ready for use, and will be included in the next release. Any class lacking "ready_for_release" should be considered likely to change place in hierarchy, have its definition refined, or be obsoleted in the next release. Those classes deemed "ready_for_release" will also derived from a chain of ancestor classes that are also "ready_for_release." + ready for release + + + + + + + + + metadata incomplete + Class is being worked on; however, the metadata (including definition) are not complete or sufficiently clear to the branch editors. + metadata incomplete + + + + + + + + + uncurated + Nothing done yet beyond assigning a unique class ID and proposing a preferred term. + uncurated + + + + + + + + + pending final vetting + All definitions, placement in the asserted IS_A hierarchy and required minimal metadata are complete. The class is awaiting a final review by someone other than the term editor. + pending final vetting + + + + + + + + + placeholder removed + placeholder removed + + + + + + + + + terms merged + An editor note should explain what were the merged terms and the reason for the merge. + terms merged + + + + + + + + + term imported + This is to be used when the original term has been replaced by a term imported from an other ontology. An editor note should indicate what is the URI of the new term to use. + term imported + + + + + + + + + term split + This is to be used when a term has been split in two or more new terms. An editor note should indicate the reason for the split and indicate the URIs of the new terms created. + term split + + + + + + + + + universal + Hard to give a definition for. Intuitively a "natural kind" rather than a collection of any old things, which a class is able to be, formally. At the meta level, universals are defined as positives, are disjoint with their siblings, have single asserted parents. + Alan Ruttenberg + A Formal Theory of Substances, Qualities, and Universals, http://ontology.buffalo.edu/bfo/SQU.pdf + universal + + + + + + + + + defined class + A defined class is a class that is defined by a set of logically necessary and sufficient conditions but is not a universal + "definitions", in some readings, always are given by necessary and sufficient conditions. So one must be careful (and this is difficult sometimes) to distinguish between defined classes and universal. + Alan Ruttenberg + defined class + + + + + + + + + named class expression + A named class expression is a logical expression that is given a name. The name can be used in place of the expression. + named class expressions are used in order to have more concise logical definition but their extensions may not be interesting classes on their own. In languages such as OWL, with no provisions for macros, these show up as actuall classes. Tools may with to not show them as such, and to replace uses of the macros with their expansions + Alan Ruttenberg + named class expression + + + + + + + + + to be replaced with external ontology term + Terms with this status should eventually replaced with a term from another ontology. + Alan Ruttenberg + group:OBI + to be replaced with external ontology term + + + + + + + + + requires discussion + A term that is metadata complete, has been reviewed, and problems have been identified that require discussion before release. Such a term requires editor note(s) to identify the outstanding issues. + Alan Ruttenberg + group:OBI + requires discussion + + + + + + + + + The term was added to the ontology on the assumption it was in scope, but it turned out later that it was not. + This obsolesence reason should be used conservatively. Typical valid examples are: un-necessary grouping classes in disease ontologies, a phenotype term added on the assumption it was a disease. + + https://github.com/information-artifact-ontology/ontology-metadata/issues/77 + https://orcid.org/0000-0001-5208-3432 + out of scope + + + + + + + + + The term was added to the ontology on the assumption it was a valid domain entity, but it turns out the entity does not exist in reality. + This obsolesence reason should be used conservatively. For example: Obsoleting class that describes a breed of cow based on a record in an existing database, that was later retracted as faulty (breed does not exist). Do not use this term to obsolete a historic concept (that was once valid, but not anymore). + + https://github.com/information-artifact-ontology/ontology-metadata/issues/136 + https://orcid.org/0000-0002-4142-7153 + domain entity does not exist + + + + + + + + + + + + + + + + + + + + + + + + + + + + diff --git a/external-dev/envo-slim.owl b/external-dev/envo-slim.owl index 54a4e914..8e77eadd 100644 --- a/external-dev/envo-slim.owl +++ b/external-dev/envo-slim.owl @@ -35,14 +35,14 @@ https://github.com/EnvironmentOntology/envo/ https://github.com/EnvironmentOntology/envo/issues/ Slimmer - 2024-07-01 01:47:59 + 2024-10-08 14:05:22 ENVO Includes Ontology(OntologyID(OntologyIRI(<http://purl.obolibrary.org/obo/envo/modules/chemical_concentration.owl>) VersionIRI(<null>))) [Axioms: 679 Logical Axioms: 119] Includes Ontology(OntologyID(OntologyIRI(<http://purl.obolibrary.org/obo/envo/modules/entity_attribute.owl>) VersionIRI(<null>))) [Axioms: 206 Logical Axioms: 34] Includes Ontology(OntologyID(OntologyIRI(<http://purl.obolibrary.org/obo/envo/modules/entity_attribute_location.owl>) VersionIRI(<null>))) [Axioms: 168 Logical Axioms: 29] Includes Ontology(OntologyID(OntologyIRI(<http://purl.obolibrary.org/obo/envo/modules/entity_quality_location.owl>) VersionIRI(<null>))) [Axioms: 40 Logical Axioms: 6] Includes Ontology(OntologyID(OntologyIRI(<http://purl.obolibrary.org/obo/envo/modules/process_attribute.owl>) VersionIRI(<null>))) [Axioms: 21 Logical Axioms: 2] - 2024-02-16 + 2024-07-01 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. http://environmentontology.org/ @@ -646,6 +646,13 @@ + + + + + + + @@ -2539,6 +2546,7 @@ The lower boundary that separates soil from the nonsoil underneath is most diffi ENVO + pulp and paper wastewater ENVO:00002193 pulp-bleaching waste water @@ -5381,6 +5389,7 @@ On the uplands, they are thin, poor and gravelly, sandy, or stony and porous, li ORCID:0000-0002-4366-3088 2010-03-15T11:17:06Z ENVO + salt marsh ENVO:01000022 marine salt marsh biome @@ -6071,6 +6080,8 @@ On the uplands, they are thin, poor and gravelly, sandy, or stony and porous, li A portion of planktonic material is a portion of environmental material primarily composed of plankton. See Issue #251. Awaiting class creation in PCO to attempt logical definitions. + mass of plankton + plankton envoPolar planktonic material @@ -13115,6 +13126,68 @@ Currently the new ice classes are not specific to sea water as they may form in + + + + + + A lake underneath the surface of the Earth. + + 2024-05-18T06:05:30Z + subterranean lake + + + + + A lake underneath the surface of the Earth. + https://en.wikipedia.org/wiki/Underground_lake + + + + + + + + + + Sediment that is part of a mangrove biome. + + 2024-05-18T06:13:48Z + mangrove sediment + Mangroves are widely recognised as key ecosystems for climate change mitigation as they capture and store significant amounts of sediment organic carbon (SOC). + mangrove biome sediment + + + + + + + + + + Sediment that is part of a salt marsh. + + 2024-05-18T06:21:33Z + marine salt marsh sediment + + + + + + + + + + + Solid material that has a waste role. + + 2024-05-19T05:18:16Z + solid waste + solid waste material + + + + @@ -13667,6 +13740,107 @@ Currently the new ice classes are not specific to sea water as they may form in + + + + + + A fume containing volatile organic compounds produced through the process of electroplating + + 2024-01-19T18:28:58Z + electroplating fume + + + + + + + + + + A fume containing solid particles of solder, produced through the process of melting solder to join multiple metals together. + + 2024-01-19T18:31:53Z + soldering fumes + + + + + + + + + + + + + + A metallic material which is composed of two or more metals and used to create a permanent bond between metal workpieces. + + 2024-01-19T18:33:47Z + solder + + + + + A metallic material which is composed of two or more metals and used to create a permanent bond between metal workpieces. + https://www.wikidata.org/wiki/Q866612 + + + + + + + + + + A solder which includes lead. + + 2024-01-19T18:34:02Z + lead solder + + + + + + + + + + A solder which is composed without lead. + + 2024-01-19T18:34:10Z + non-lead solder + + + + + + + + + + A fume produced by liquid gasoline, containing aerosolized components of the gasoline. + + 2024-01-19T18:39:48Z + gasoline vapor + + + + + + + + + + A smoke which is inhaled involuntarily from a tobacco product smoked by another individual. + + 2024-01-19T18:57:57Z + secondhand smoke + + + + diff --git a/external-dev/fabio-slim.owl b/external-dev/fabio-slim.owl index c53898b3..3407c5cb 100644 --- a/external-dev/fabio-slim.owl +++ b/external-dev/fabio-slim.owl @@ -33,7 +33,7 @@ FaBiO classes are structured according to the FRBR schema of Works, Expressions, fabio http://purl.org/spar/fabio/ Slimmer - 2024-07-01 01:48:03 + 2024-10-08 14:05:27 FaBiO, the FRBR-aligned Bibliographic Ontology, is an ontology for recording and publishing on the Semantic Web bibliographic records of scholarly endeavours. It forms part of SPAR, a suite of Semantic Publishing and Referencing Ontologies. Other SPAR ontologies are described at http://purl.org/spar/. This ontology is available at http://purl.org/spar/fabio, and uses the namespace prefix fabio. diff --git a/external-dev/go-slim.owl b/external-dev/go-slim.owl index 68fd433e..8ae1d706 100644 --- a/external-dev/go-slim.owl +++ b/external-dev/go-slim.owl @@ -13,7 +13,6 @@ xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:ncicp="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#" xmlns:terms="http://purl.org/dc/terms/" - xmlns:terms2="http://www.geneontology.org/formats/oboInOwl#http://purl.org/dc/terms/" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"> @@ -24,10 +23,10 @@ http://purl.obolibrary.org/obo/go.owl Slimmer - 2024-07-01 01:48:27 + 2024-10-08 14:05:48 gene_ontology 1.2 - 2024-06-17 + 2024-09-08 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. @@ -599,13 +598,6 @@ - - - - - - - @@ -867,7 +859,7 @@ activation of metacaspase activity biological_process GO:0006919 - + This term should be used when the annotation refers to a process that occurs in a context of apoptotic cell death. To annotate gene products involved in activation of cysteine-type endopeptidases in other cellular process (e.g., cell cycle arrest) that do not necessarily develop into an apoptotic process, please use the more general parent term GO:0097202. Examples of 'activation of cysteine-type endopeptidase activity involved in apoptotic process' are cytochrome c and Apaf1. When cytochrome c is released from mitochondria and forms a complex with Apaf1, they form a scaffolding platform in which the pro-caspase 9 is bound (the 'apoptosome'). The caspase is then cleaved and activated. Cytochrome c and Apaf1 are therefore involved in the conversion of the zymogen procaspase 9 to the active form of the caspase. activation of cysteine-type endopeptidase activity involved in apoptotic process @@ -1081,7 +1073,7 @@ activation of caspase activity by cytochrome c biological_process GO:0008635 - + activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c @@ -2530,7 +2522,7 @@ inhibition of caspase activity biological_process GO:0043154 - + negative regulation of cysteine-type endopeptidase activity involved in apoptotic process @@ -2587,7 +2579,7 @@ stimulation of caspase activity biological_process GO:0043280 - + positive regulation of cysteine-type endopeptidase activity involved in apoptotic process @@ -2611,7 +2603,7 @@ regulation of caspase activation biological_process GO:0043281 - + regulation of cysteine-type endopeptidase activity involved in apoptotic process @@ -2695,25 +2687,6 @@ - - - - - - Any process that modulates the frequency, rate or extent of the transfer of one or more phosphate groups to an actin molecule. - biological_process - GO:0043538 - regulation of actin phosphorylation - - - - - Any process that modulates the frequency, rate or extent of the transfer of one or more phosphate groups to an actin molecule. - GOC:go_curators - - - - @@ -3906,7 +3879,7 @@ activation of initiator caspase activity biological_process GO:0097296 - + Components of the DISC (death-inducing signaling complex) may be annotated to this term. These include ligand-bound receptors such as FAS/CD95 (though care should be taken because FAS can also act as a non-apoptotic signal transducer), and signaling molecules such as FADD (FAS-associated protein with a death domain), cIAPs (cellular inhibitor of apoptosis proteins), c-FLIPs and caspases 8 and 10. Note that GO:0097296 should only be used to annotate gene products directly involved in the initiation or start up of an inactive cysteine-type endopeptidase activity involved in the apoptotic signaling pathway (also known as an initiator caspase). If the evidence provided is not sufficient to account for direct activation of this enzymatic activity, consider using the more generic terms GO:2001269 positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway or GO:0043280 positive regulation of cysteine-type endopeptidase activity involved in apoptotic process. activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway @@ -8708,7 +8681,7 @@ 2012-12-05T15:42:50Z biological_process GO:1990001 - + inhibition of cysteine-type endopeptidase activity involved in apoptotic process @@ -9226,7 +9199,7 @@ regulation of initiator caspase activity biological_process GO:2001267 - + regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway @@ -9263,7 +9236,7 @@ negative regulation of initiator caspase activity biological_process GO:2001268 - + negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway @@ -9300,7 +9273,7 @@ positive regulation of initiator caspase activity biological_process GO:2001269 - + positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway @@ -9335,7 +9308,7 @@ regulation of effector caspase activity biological_process GO:2001270 - + regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis @@ -9365,7 +9338,7 @@ negative regulation of effector caspase activity biological_process GO:2001271 - + negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis @@ -9395,7 +9368,7 @@ positive regulation of effector caspase activity biological_process GO:2001272 - + positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis @@ -9974,6 +9947,20 @@ results_in_fusion_of results in fusion of + + RO:0012013 + external + positively_regulates_in_another_organism + positively_regulates_in_another_organism + positively regulates in another organism + + + RO:0012014 + external + negatively_regulates_in_another_organism + negatively_regulates_in_another_organism + negatively regulates in another organism + RO:0019000 gene_ontology diff --git a/external-dev/iao-slim.owl b/external-dev/iao-slim.owl index 4387a9b9..7cee1a16 100644 --- a/external-dev/iao-slim.owl +++ b/external-dev/iao-slim.owl @@ -57,7 +57,7 @@ http://purl.obolibrary.org/obo/iao.owl Slimmer - 2024-07-01 01:48:29 + 2024-10-08 14:05:50 An information artifact is, loosely, a dependent continuant or its bearer that is created as the result of one or more intentional processes. Examples: uniprot, the english language, the contents of this document or a printout of it, the temperature measurements from a weather balloon. For more information, see the project home page at https://github.com/information-artifact-ontology/IAO IDs allocated to related efforts: PNO: IAO_0020000-IAO_0020999, D_ACTS: IAO_0021000-IAO_0021999 IDs allocated to subdomains of IAO. pno.owl: IAO_0020000-IAO_0020999, d-acts.owl: IAO_0021000-IAO_0021999 diff --git a/external-dev/msio-slim.owl b/external-dev/msio-slim.owl index 34f2b03c..e2a8d765 100644 --- a/external-dev/msio-slim.owl +++ b/external-dev/msio-slim.owl @@ -181,7 +181,7 @@ http://www.cosmos-fp7.eu/WP2 Slimmer Daniel Schober 2017-10-19T10:11:26Z - 2024-07-01 01:51:28 + 2024-10-08 14:08:52 Please see the project site https://github.com/BFO-ontology/BFO, the bfo2 owl discussion group http://groups.google.com/group/bfo-owl-devel, the bfo2 discussion group http://groups.google.com/group/bfo-devel, the tracking google doc http://goo.gl/IlrEE, and the current version of the bfo2 reference http://purl.obolibrary.org/obo/bfo/dev/bfo2-reference.docx. This ontology is generated from a specification at https://github.com/BFO-ontology/BFO/tree/master/src/ontology/owl-group/specification/ and with the code that generates the OWL version in https://github.com/BFO-ontology/BFO/tree/master/src/tools/. A very early version of BFO version 2 in CLIF is at http://purl.obolibrary.org/obo/bfo/dev/bfo.clif. The BSD license on the BFO project site refers to code used to build BFO. This version (1.1.0) uses the Basic Formal Ontology (BFO) as its top level ontology. We might at some point close the resulting semantic gap by using OBI and IAO as intermediate bridges. diff --git a/external-dev/ncit-slim.owl b/external-dev/ncit-slim.owl index 52fb47a9..605e58bc 100644 --- a/external-dev/ncit-slim.owl +++ b/external-dev/ncit-slim.owl @@ -21,7 +21,7 @@ NCI Thesaurus OBO Edition http://purl.obolibrary.org/obo/ncit.owl Slimmer - 2024-07-01 01:50:37 + 2024-10-08 14:08:01 NCI Thesaurus, a controlled vocabulary in support of NCI administrative and scientific activities. Produced by the Enterprise Vocabulary System (EVS), a project by the NCI Center for Biomedical Informatics and Information Technology. National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, U.S.A. 24.04e This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/npo-slim-prop.owl b/external-dev/npo-slim-prop.owl index f6e747ff..cac3d11c 100644 --- a/external-dev/npo-slim-prop.owl +++ b/external-dev/npo-slim-prop.owl @@ -1,13 +1,13 @@ - - + diff --git a/external-dev/npo-slim.owl b/external-dev/npo-slim.owl index 9b52553a..702b11e9 100644 --- a/external-dev/npo-slim.owl +++ b/external-dev/npo-slim.owl @@ -17,7 +17,7 @@ http://purl.bioontology.org/ontology/npo https://raw.githubusercontent.com/enanomapper/npo/master/npo-inferred.owl Slimmer - 2024-07-01 01:50:41 + 2024-10-08 14:08:05 Inferred version created with Pellet reasoner in Protege editor (v. 4.1) The NPO was primarily developed by Dennis G. Thomas in collaboration with Nathan A. Baker and Rohit V. Pappu. This development was supported by the NIH through grants U54 CA119342 and U54 HG004028. 2013-05-31 (yyyy-mm-dd) diff --git a/external-dev/oae-slim.owl b/external-dev/oae-slim.owl index b53db98d..ff982e91 100644 --- a/external-dev/oae-slim.owl +++ b/external-dev/oae-slim.owl @@ -58,7 +58,7 @@ OAE: Ontology of Adverse Events http://purl.obolibrary.org/obo/oae.owl Slimmer - 2024-07-01 01:50:47 + 2024-10-08 14:08:11 1.2.47 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/obcs-slim.owl b/external-dev/obcs-slim.owl index 78c056d3..ede550ce 100644 --- a/external-dev/obcs-slim.owl +++ b/external-dev/obcs-slim.owl @@ -37,7 +37,7 @@ http://purl.obolibrary.org/obo/obcs.owl Slimmer - 2024-07-01 01:50:51 + 2024-10-08 14:08:15 2023-12-08 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/obi-slim.owl b/external-dev/obi-slim.owl index e2f9d4c7..054a5cec 100644 --- a/external-dev/obi-slim.owl +++ b/external-dev/obi-slim.owl @@ -82,7 +82,7 @@ Ontology for Biomedical Investigations http://purl.obolibrary.org/obo/obi.owl Slimmer - 2024-07-01 01:50:56 + 2024-10-08 14:08:20 Please cite the OBI consortium http://purl.obolibrary.org/obo/obi where traditional citation is called for. However it is adequate that individual terms be attributed simply by use of the identifying PURL for the term, in projects that refer to them. 2024-06-10 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/pato-slim.owl b/external-dev/pato-slim.owl index 9d74be00..e55f33a8 100644 --- a/external-dev/pato-slim.owl +++ b/external-dev/pato-slim.owl @@ -4,34 +4,24 @@ xmlns:cl="http://purl.obolibrary.org/obo/cl#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:go="http://purl.obolibrary.org/obo/go#" - xmlns:pr="http://purl.obolibrary.org/obo/pr#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:pav="http://purl.org/pav/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:xml="http://www.w3.org/XML/1998/namespace" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" - xmlns:cito="http://purl.org/spar/cito/" xmlns:core="http://purl.obolibrary.org/obo/uberon/core#" xmlns:foaf="http://xmlns.com/foaf/0.1/" - xmlns:obo1="http://www.geneontology.org/formats/oboInOwl#http://purl.obolibrary.org/obo/" xmlns:pato="http://purl.obolibrary.org/obo/pato#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" - xmlns:skos="http://www.w3.org/2004/02/skos/core#" - xmlns:chebi="http://purl.obolibrary.org/obo/chebi/" + xmlns:chebi="http://purl.obolibrary.org/obo/chebi#1" xmlns:ncicp="http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#" - xmlns:sssom="https://w3id.org/sssom/" - xmlns:swrla="http://swrl.stanford.edu/ontologies/3.3/swrla.owl#" xmlns:terms="http://purl.org/dc/terms/" - xmlns:vocab="https://w3id.org/semapv/vocab/" - xmlns:chebi2="http://purl.obolibrary.org/obo/chebi#" - xmlns:chebi3="http://purl.obolibrary.org/obo/chebi#1" - xmlns:chebi4="http://purl.obolibrary.org/obo/chebi#3" - xmlns:chebi5="http://purl.obolibrary.org/obo/chebi#2" + xmlns:chebi1="http://purl.obolibrary.org/obo/chebi#3" + xmlns:chebi2="http://purl.obolibrary.org/obo/chebi#2" xmlns:ubprop="http://purl.obolibrary.org/obo/ubprop#" xmlns:subsets="http://purl.obolibrary.org/obo/ro/subsets#" - xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" - xmlns:ncbitaxon="http://purl.obolibrary.org/obo/ncbitaxon#"> + xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"> An ontology of phenotypic qualities (properties, attributes or characteristics). @@ -39,10 +29,10 @@ http://purl.obolibrary.org/obo/pato.owl Slimmer - 2024-07-01 01:51:03 + 2024-10-08 14:08:28 quality 1.2 - 2024-03-28 + 2024-09-04 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. @@ -60,27 +50,6 @@ - - - - - - - - - - - - - - - - - - - - - @@ -90,34 +59,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -125,41 +66,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -167,13 +73,6 @@ - - - - - - - @@ -183,86 +82,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -272,53 +91,10 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - If R <- P o Q is a defining property chain axiom, then it also holds that R -> P o Q. Note that this cannot be expressed directly in OWL - is a defining property chain axiom - - - - - - - - - If R <- P o Q is a defining property chain axiom, then (1) R -> P o Q holds and (2) Q is either reflexive or locally reflexive. A corollary of this is that P SubPropertyOf R. - is a defining property chain axiom where second argument is reflexive - - - - - 'anterior end of organism' is-opposite-of 'posterior end of organism' - 'increase in temperature' is-opposite-of 'decrease in temperature' x is the opposite of y if there exists some distance metric M, and there exists no z such as M(x,z) <= M(x,y) or M(y,z) <= M(y,x). RO:0002604 quality @@ -332,139 +108,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -501,24 +144,6 @@ - - - - - - - - - - - - - - - - - - @@ -546,55 +171,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -658,15 +234,6 @@ - - - - - - - - - @@ -703,6 +270,15 @@ + + + + + + + + + @@ -757,117 +333,56 @@ - + - + - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - + - - + + - + - + + + - + - - + + - + - - + + - + - - + + @@ -979,24 +494,6 @@ - - - - - - - - - - - - - - - - - - @@ -1006,51 +503,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -1282,13 +734,6 @@ - - - - - - - @@ -1310,13 +755,6 @@ - - - - - - - @@ -1331,20 +769,6 @@ - - - - - - - - - - - - - - @@ -1354,13 +778,6 @@ - - - - - - - @@ -1377,13 +794,6 @@ - - - - - - - @@ -1409,13 +819,6 @@ - - - - - - - @@ -1423,62 +826,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -1549,13 +896,6 @@ - - - - - - - @@ -1574,20 +914,6 @@ - - - - - - - - - - - - - - @@ -1595,13 +921,6 @@ - - - - - - - @@ -1609,41 +928,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -1653,62 +937,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - @@ -1723,17 +951,6 @@ - - - - - http://www.w3.org/2000/01/rdf-schema#seeAlso - seeAlso - see also - - - - @@ -1741,20 +958,6 @@ - - - - - - - - - - - - - - @@ -1762,34 +965,6 @@ - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - disposition - + - - quality - + @@ -1919,11 +1090,19 @@ + A quality of an entity that is descriptive or observational, typically not represented numerically. quality PATO:0000068 TODO: define this or obsolete it and move children somewhere else. qualitative + + + + A quality of an entity that is descriptive or observational, typically not represented numerically. + https://libguides.macalester.edu/c.php?g=527786&p=3608639 + https://www.ncbi.nlm.nih.gov/books/NBK470395/ + @@ -4572,7 +3751,6 @@ true has_ontology_root_term has ontology root term - preferred_root has_obo_format_version diff --git a/external-dev/sio-slim-prop.owl b/external-dev/sio-slim-prop.owl index f2279a96..1e4aa360 100644 --- a/external-dev/sio-slim-prop.owl +++ b/external-dev/sio-slim-prop.owl @@ -1,6 +1,6 @@ - - + diff --git a/external-dev/sio-slim.owl b/external-dev/sio-slim.owl index e6776e22..3ae5b3f6 100644 --- a/external-dev/sio-slim.owl +++ b/external-dev/sio-slim.owl @@ -80,7 +80,7 @@ mailing list: http://groups.google.com/group/sio-ontology role chains: 'has capability' o 'is realized in' -> 'is participant in' Slimmer - 2024-07-01 01:51:06 + 2024-10-08 14:08:30 http://sio.semanticscience.org 1.59 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer. diff --git a/external-dev/uberon-slim.owl b/external-dev/uberon-slim.owl index dba51a8e..7180da86 100644 --- a/external-dev/uberon-slim.owl +++ b/external-dev/uberon-slim.owl @@ -152,7 +152,7 @@ https://github.com/obophenotype/uberon/issues/ https://lists.sourceforge.net/lists/listinfo/obo-anatomy Slimmer - 2024-07-01 01:51:23 + 2024-10-08 14:08:47 uberon 1.2 AEO @@ -379,6 +379,13 @@ Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary. + + + + + + + @@ -452,6 +459,29 @@ Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary. x never in taxon T if and only if T is a class, and x does not instantiate the class expression "in taxon some T". Note that this is a shortcut relation, and should be used as a hasValue restriction in OWL. Class: <http://www.w3.org/2002/07/owl#Nothing> EquivalentTo: ?X and (RO_0002162 some ?Y) Class: ?X DisjointWith: RO_0002162 some ?Y + PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> +PREFIX owl: <http://www.w3.org/2002/07/owl#> +PREFIX in_taxon: <http://purl.obolibrary.org/obo/RO_0002162> +PREFIX never_in_taxon: <http://purl.obolibrary.org/obo/RO_0002161> +CONSTRUCT { + in_taxon: a owl:ObjectProperty . + ?x owl:disjointWith [ + a owl:Restriction ; + owl:onProperty in_taxon: ; + owl:someValuesFrom ?taxon + ] . + ?x rdfs:subClassOf [ + a owl:Restriction ; + owl:onProperty in_taxon: ; + owl:someValuesFrom [ + a owl:Class ; + owl:complementOf ?taxon + ] + ] . +} +WHERE { + ?x never_in_taxon: ?taxon . +} RO:0002161 uberon never_in_taxon @@ -477,6 +507,25 @@ Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary. A is mutually_spatially_disjoint_with B if both A and B are classes, and there exists no p such that p is part_of some A and p is part_of some B. Class: <http://www.w3.org/2002/07/owl#Nothing> EquivalentTo: (BFO_0000050 some ?X) and (BFO_0000050 some ?Y) + PREFIX owl: <http://www.w3.org/2002/07/owl#> +PREFIX part_of: <http://purl.obolibrary.org/obo/BFO_0000050> +PREFIX mutually_spatially_disjoint_with: <http://purl.obolibrary.org/obo/RO_0002171> +CONSTRUCT { + part_of: a owl:ObjectProperty . + [ + a owl:Restriction ; + owl:onProperty part_of: ; + owl:someValuesFrom ?x ; + owl:disjointWith [ + a owl:Restriction ; + owl:onProperty part_of: ; + owl:someValuesFrom ?y + ] + ] +} +WHERE { + ?x mutually_spatially_disjoint_with: ?y . +} RO:0002171 uberon mutually_spatially_disjoint_with @@ -548,6 +597,30 @@ Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary. S present_in_taxon T if some instance of T has some S. This does not means that all instances of T have an S - it may only be certain life stages or sexes that have S S present_in_taxon T if some instance of T has some S. This does not means that all instances of T have an S - it may only be certain life stages or sexes that have S. + PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#> +PREFIX owl: <http://www.w3.org/2002/07/owl#> +PREFIX in_taxon: <http://purl.obolibrary.org/obo/RO_0002162> +PREFIX present_in_taxon: <http://purl.obolibrary.org/obo/RO_0002175> +CONSTRUCT { + in_taxon: a owl:ObjectProperty . + ?witness rdfs:label ?label . + ?witness rdfs:subClassOf ?x . + ?witness rdfs:subClassOf [ + a owl:Restriction ; + owl:onProperty in_taxon: ; + owl:someValuesFrom ?taxon + ] . +} +WHERE { + ?x present_in_taxon: ?taxon . + BIND(IRI(CONCAT( + "http://purl.obolibrary.org/obo/RO_0002175#", + MD5(STR(?x)), + "-", + MD5(STR(?taxon)) + )) as ?witness) + BIND(CONCAT(STR(?x), " in taxon ", STR(?taxon)) AS ?label) +} RO:0002175 applicable for taxon uberon @@ -1297,6 +1370,15 @@ Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary. + + + + + + + + + @@ -2288,13 +2370,6 @@ Annotations: expand_assertion_to "DisjointClasses: (http://purl.obolibrary. - - - - - - - diff --git a/external-dev/uo-slim.owl b/external-dev/uo-slim.owl index 2af53e0e..2a8581c8 100644 --- a/external-dev/uo-slim.owl +++ b/external-dev/uo-slim.owl @@ -12,7 +12,7 @@ http://purl.obolibrary.org/obo/uo.owl Slimmer - 2024-07-01 01:51:25 + 2024-10-08 14:08:49 2023-05-25 This SLIM file was generated automatically by the eNanoMapper Slimmer software library. For more information see http://github.com/enanomapper/slimmer.